UNITED STATES
Form 10-Q
(Mark One)
|
||
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the quarterly period ended September 30, 2004 | ||
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to |
Commission file number 1-9550
Beverly Enterprises, Inc.
Delaware | 62-1691861 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
One Thousand Beverly Way
Registrants telephone number, including area code:
Registrants website:
Indicate by check mark whether Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark if Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes þ No o
Shares of Registrants Common Stock, $.10 par value, outstanding, exclusive of
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q, and other information we provide from time to time, contains certain forward-looking statements as that term is defined by the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations or cash flows, continued performance improvements, ability to service, refinance, replace and comply with our debt obligations, ability to finance growth opportunities, ability to control our patient care liability costs, ability to respond to changes in government regulations, ability to execute our three-year strategic plan, and similar statements, including, without limitation, those containing words such as believes, anticipates, expects, intends, estimates, plans, and other similar expressions, are forward-looking statements.
These forward-looking statements reflect managements beliefs and assumptions and are based on information currently available to management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by us in those statements. Numerous factors will affect our actual results, some of which are beyond our control. These include, but are not limited to:
| national and local economic conditions, including their effect on the availability and cost of labor, utilities and materials; | |
| the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; | |
| changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; | |
| the effects of adopting new accounting standards; | |
| our ability to integrate acquisitions and realize synergies and accretion; | |
| liabilities and other claims asserted against us, including patient care liabilities, as well as the resolution of lawsuits brought about by the announcement or settlement of federal government investigations and the announcement of increases in reserves for patient care liabilities; | |
| our ability to predict future reserve levels for patient care and workers compensation liabilities; | |
| our ability to obtain adequate insurance coverage with financially viable insurance carriers, as well as the ability of our insurance carriers to fulfill their obligations; | |
| our ability to execute strategic divestitures in a timely manner at fair values; | |
| our ability to improve our fundamental business processes and reduce costs throughout the organization; | |
| our ability to attract and retain qualified personnel; | |
| the availability and terms of capital to fund acquisitions, capital improvements and ongoing operations; | |
| our ability to repurchase our stock and changes in our stock price after any such repurchases; | |
| the competitive environment in which we operate; | |
| our ability to maintain and increase census (volume of residents) levels; and | |
| demographic changes. |
Investors should also refer to Item 1. Business in our Annual Report on Form 10-K for the fiscal year ended December 31, 2003, as amended, for a discussion of various governmental regulations and other operating factors relating to the healthcare industry and the risks inherent in them. You should carefully consider the risks described and referred to in this report before making any investment decisions in the Company. There may be additional risks that we do not presently know of or that we currently do not deem
1
2
BEVERLY ENTERPRISES, INC.
FORM 10-Q
September 30, 2004
TABLE OF CONTENTS
3
PART I
ITEM 1. FINANCIAL STATEMENTS.
BEVERLY ENTERPRISES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
September 30, | December 31, | |||||||||
2004 | 2003 | |||||||||
(Unaudited) | (Note) | |||||||||
ASSETS | ||||||||||
Current assets:
|
||||||||||
Cash and cash equivalents
|
$ | 207,360 | $ | 258,815 | ||||||
Accounts receivable, less allowance for doubtful
accounts: 2004 $33,326; 2003 $31,615
|
215,338 | 164,635 | ||||||||
Notes receivable, less allowance for doubtful
notes: 2004 $2,300; 2003 $3,336
|
6,499 | 13,724 | ||||||||
Operating supplies
|
9,250 | 10,425 | ||||||||
Assets held for sale
|
15,128 | 3,498 | ||||||||
Investment in Beverly Funding Corporation
|
| 31,342 | ||||||||
Prepaid expenses and other
|
39,135 | 33,377 | ||||||||
Total current assets
|
492,710 | 515,816 | ||||||||
Property and equipment, net
|
646,860 | 694,220 | ||||||||
Other assets:
|
||||||||||
Goodwill, net
|
124,467 | 57,102 | ||||||||
Other, less allowance for doubtful accounts and
notes: 2004 $1,462; 2003 $2,120
|
70,635 | 79,283 | ||||||||
Total other assets
|
195,102 | 136,385 | ||||||||
$ | 1,334,672 | $ | 1,346,421 | |||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities:
|
||||||||||
Accounts payable
|
$ | 59,081 | $ | 67,572 | ||||||
Accrued wages and related liabilities
|
95,478 | 116,717 | ||||||||
Accrued interest
|
9,066 | 6,896 | ||||||||
General and professional liabilities
|
63,422 | 93,736 | ||||||||
Federal government settlement obligations
|
14,064 | 13,125 | ||||||||
Liabilities held for sale
|
622 | 672 | ||||||||
Other accrued liabilities
|
87,143 | 102,289 | ||||||||
Current portion of long-term debt
|
11,644 | 13,354 | ||||||||
Total current liabilities
|
340,520 | 414,361 | ||||||||
Long-term debt
|
558,488 | 552,873 | ||||||||
Other liabilities and deferred items
|
173,971 | 141,001 | ||||||||
Commitments and contingencies
|
||||||||||
Stockholders equity:
|
||||||||||
Preferred stock, shares authorized: 25,000,000
|
| | ||||||||
Common stock, shares issued: 2004
116,241,478; 2003 115,594,806
|
11,624 | 11,559 | ||||||||
Additional paid-in capital
|
897,476 | 895,950 | ||||||||
Accumulated deficit
|
(538,909 | ) | (560,825 | ) | ||||||
Treasury stock, at cost: 8,283,316
|
(108,498 | ) | (108,498 | ) | ||||||
Total stockholders equity
|
261,693 | 238,186 | ||||||||
$ | 1,334,672 | $ | 1,346,421 | |||||||
Note: | The balance sheet at December 31, 2003 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. |
See accompanying notes.
4
BEVERLY ENTERPRISES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended | Nine Months Ended | ||||||||||||||||||
September 30, | September 30, | ||||||||||||||||||
2004 | 2003 | 2004 | 2003 | ||||||||||||||||
Revenues
|
$ | 508,169 | $ | 461,201 | $ | 1,486,304 | $ | 1,345,030 | |||||||||||
Costs and expenses:
|
|||||||||||||||||||
Wages and related
|
300,734 | 275,922 | 856,406 | 807,289 | |||||||||||||||
Provision for insurance and related items
|
29,407 | 27,892 | 90,381 | 82,165 | |||||||||||||||
Other operating and administrative
|
131,560 | 116,498 | 391,449 | 346,869 | |||||||||||||||
Depreciation and amortization
|
15,918 | 14,783 | 46,241 | 43,634 | |||||||||||||||
Adjustment related to California investigation
settlement
|
| | | (925 | ) | ||||||||||||||
Asset impairments, workforce reductions and other
unusual items
|
(613 | ) | 1,343 | 1,188 | 2,672 | ||||||||||||||
Total costs and expenses
|
477,006 | 436,438 | 1,385,665 | 1,281,704 | |||||||||||||||
Income before other income (expenses)
|
31,163 | 24,763 | 100,639 | 63,326 | |||||||||||||||
Other income (expenses):
|
|||||||||||||||||||
Interest expense
|
(11,122 | ) | (16,029 | ) | (35,068 | ) | (47,761 | ) | |||||||||||
Costs related to early extinguishment of debt
|
(176 | ) | | (40,430 | ) | | |||||||||||||
Interest income
|
1,246 | 1,170 | 4,089 | 3,554 | |||||||||||||||
Net gains on dispositions
|
582 | 2 | 614 | 399 | |||||||||||||||
Total other expenses, net
|
(9,470 | ) | (14,857 | ) | (70,795 | ) | (43,808 | ) | |||||||||||
Income before provision for income taxes and
discontinued operations
|
21,693 | 9,906 | 29,844 | 19,518 | |||||||||||||||
Provision for income taxes
|
536 | 1,853 | 3,038 | 4,290 | |||||||||||||||
Income before discontinued operations
|
21,157 | 8,053 | 26,806 | 15,228 | |||||||||||||||
Discontinued operations, net of taxes: for the
quarters 2004 $(59) and 2003 $0; for the
nine months 2004 $286 and 2003 $0
|
3,243 | 1,930 | (4,890 | ) | 24,434 | ||||||||||||||
Net income
|
$ | 24,400 | $ | 9,983 | $ | 21,916 | $ | 39,662 | |||||||||||
Net income (loss) per share of common stock:
|
|||||||||||||||||||
Basic:
|
|||||||||||||||||||
Before discontinued operations
|
$ | 0.20 | $ | 0.08 | $ | 0.25 | $ | 0.14 | |||||||||||
Discontinued operations
|
0.03 | 0.01 | (0.05 | ) | 0.23 | ||||||||||||||
Net income (loss) per share of common stock
|
$ | 0.23 | $ | 0.09 | $ | 0.20 | $ | 0.37 | |||||||||||
Shares used to compute basic net income (loss)
per share
|
108,039 | 107,142 | 107,613 | 106,356 | |||||||||||||||
Diluted:
|
|||||||||||||||||||
Before discontinued operations
|
$ | 0.19 | $ | 0.07 | $ | 0.25 | $ | 0.14 | |||||||||||
Discontinued operations
|
0.03 | 0.02 | (0.05 | ) | 0.23 | ||||||||||||||
Net income (loss) per share of common stock
|
$ | 0.22 | $ | 0.09 | $ | 0.20 | $ | 0.37 | |||||||||||
Shares used to compute diluted net income (loss)
per share
|
109,061 | 107,600 | 108,673 | 106,510 | |||||||||||||||
See accompanying notes
5
BEVERLY ENTERPRISES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended | ||||||||||||
September 30, | ||||||||||||
2004 | 2003 | |||||||||||
Cash flows from operating activities:
|
||||||||||||
Net income
|
$ | 21,916 | $ | 39,662 | ||||||||
Adjustments to reconcile net income to net cash
provided by (used for) operating activities, including
discontinued operations:
|
||||||||||||
Depreciation and amortization
|
47,656 | 52,845 | ||||||||||
Provision for reserves on accounts, notes and
other receivables, net
|
10,772 | 22,670 | ||||||||||
Amortization of deferred financing costs
|
2,107 | 3,655 | ||||||||||
Costs related to early extinguishments of debt
|
40,430 | | ||||||||||
Asset impairments, workforce reductions and other
unusual items
|
3,799 | 5,224 | ||||||||||
Gains on dispositions of facilities and other
assets, net
|
(455 | ) | (47,254 | ) | ||||||||
Adjustment related to California investigation
settlement
|
| (925 | ) | |||||||||
Insurance related accounts
|
(12,833 | ) | 4,189 | |||||||||
Changes in operating assets and liabilities, net
of acquisitions and dispositions:
|
||||||||||||
Accounts receivable
|
(53,955 | ) | (20,153 | ) | ||||||||
Prepaid expenses
|
8,139 | (6,635 | ) | |||||||||
Accounts payable and other accrued expenses
|
(23,140 | ) | 2,501 | |||||||||
Income taxes
|
(2,497 | ) | 2,337 | |||||||||
Other, net
|
(4,219 | ) | (4,689 | ) | ||||||||
Total adjustments
|
15,804 | 13,765 | ||||||||||
Net cash provided by operating activities
|
37,720 | 53,427 | ||||||||||
Cash flows from investing activities:
|
||||||||||||
Capital expenditures
|
(37,964 | ) | (29,054 | ) | ||||||||
Payments for acquisitions, net of cash acquired
|
(71,479 | ) | (404 | ) | ||||||||
Proceeds from dispositions of facilities and
other assets, net
|
22,346 | 173,102 | ||||||||||
Proceeds from Beverly Funding Corporation
investment
|
28,956 | | ||||||||||
Collections on notes receivable
|
32,268 | 510 | ||||||||||
Payments for designated funds, net
|
(958 | ) | (5,320 | ) | ||||||||
Other, net
|
(24,316 | ) | (9,010 | ) | ||||||||
Net cash (used for) provided by investing
activities
|
(51,147 | ) | 129,824 | |||||||||
Cash flows from financing activities:
|
||||||||||||
Repayments of long-term debt
|
(207,479 | ) | (58,212 | ) | ||||||||
Repayments of off-balance sheet financing
|
| (69,456 | ) | |||||||||
Proceeds from issuance of new debt
|
211,384 | | ||||||||||
Proceeds from exercise of stock options
|
1,399 | 98 | ||||||||||
Deferred financing and other costs
|
(43,332 | ) | (2,409 | ) | ||||||||
Net cash used for financing activities
|
(38,028 | ) | (129,979 | ) | ||||||||
Net increase (decrease) in cash and cash
equivalents
|
(51,455 | ) | 53,272 | |||||||||
Cash and cash equivalents at beginning of period
|
258,815 | 115,445 | ||||||||||
Cash and cash equivalents at end of period
|
$ | 207,360 | $ | 168,717 | ||||||||
Supplemental schedule of cash flow information:
|
||||||||||||
Cash paid during the period for:
|
||||||||||||
Interest, net of amounts capitalized
|
$ | 30,969 | $ | 45,799 | ||||||||
Income tax payments, net
|
5,821 | 1,953 |
See accompanying notes.
6
BEVERLY ENTERPRISES, INC.
Note 1. | General |
Basis of Presentation |
References throughout this document to the Company include Beverly Enterprises, Inc. and its wholly owned subsidiaries. In accordance with the Securities and Exchange Commissions Plain English guidelines, this Quarterly Report on Form 10-Q has been written in the first person. In this document, the words we, our, ours and us refer only to Beverly Enterprises, Inc. and its wholly owned subsidiaries and not to any other person.
We have prepared these condensed consolidated financial statements without audit. In managements opinion, these condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the results of operations for the three-month and nine-month periods ended September 30, 2004 and 2003 in accordance with the rules and regulations of the Securities and Exchange Commission (SEC). Although certain information and footnote disclosures required by generally accepted accounting principles in the United States have been condensed or omitted, we believe that the disclosures in these condensed consolidated financial statements are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read along with our Annual Report on Form 10-K for the fiscal year ended December 31, 2003, as amended, filed with the SEC. Our results of operations for the three-month and nine-month periods ended September 30, 2004 are not necessarily indicative of the results for a full year.
Reclassification |
Certain prior year amounts have been reclassified to conform with the 2004 financial statement presentation. Assets and liabilities held for sale are reported based on their status as of the balance sheet date.
Use of Estimates |
Generally accepted accounting principles in the United States require management to make estimates and assumptions when preparing financial statements that affect:
| the reported amounts of assets and liabilities at the date of the financial statements; and | |
| the reported amounts of revenues and expenses during the reporting period. |
They also require management to make estimates and assumptions regarding contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Transfers of Financial Assets |
During 2003 and through February 29, 2004, we, through our wholly owned subsidiary Beverly Health and Rehabilitation Services, Inc. (BHRS), sold on a revolving basis certain Medicaid and Veterans Administration (VA) accounts receivable to a non-consolidated bankruptcy remote, qualifying special purpose entity, Beverly Funding Corporation (BFC), at a discount of 1%. These daily transactions constituted true sales of receivables for which BFC bore the risk of collection. We retained servicing responsibilities for the transferred receivables. We accounted for the transfers of receivables as sales in accordance with Statement of Financial Accounting Standards No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities (SFAS No. 140).
In accordance with its medium-term notes agreement, BFC ceased purchasing receivables from BHRS on March 1, 2004. Cash collections on and after March 1, 2004, on receivables purchased by BFC prior to
7
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 1. | General (Continued) |
March 1, 2004, were accumulated by BFC to repay its $70.0 million of medium-term notes on June 15, 2004. Upon repayment of the medium-term notes on June 15, 2004, BFC no longer had third-party beneficial owners and, therefore, no longer met the conditions of a qualifying special purpose entity, in accordance with SFAS No. 140. Therefore, during the second quarter of 2004, we reconsolidated the remaining balances of BFC with us.
At December 31, 2003, we had an investment in BFC of approximately $31.3 million. The investment was recorded at its estimated fair value and was subjected to periodic review for other than temporary impairment. Prior to consolidation, we received $29.0 million of cash from BFC as a return on our investment. The remaining investment balance was recovered through cash collections on the reconsolidated receivables owned by BFC.
Activities related to the revolving sales structure with BFC were as follows for the three-month and nine-month periods ended September 30 (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
New receivables sold
|
$ | | $ | 207,159 | $ | 119,360 | $ | 629,768 | ||||||||
Cash collections remitted
|
3,513 | 212,722 | 197,123 | 632,281 | ||||||||||||
Fees received for servicing
|
14 | 539 | 658 | 1,604 | ||||||||||||
Loss on sale of receivables
|
| (2,072 | ) | (1,194 | ) | (6,298 | ) |
BHRS provided invoicing and collection services related to the receivables owned by BFC for a market-based servicing fee. BHRS recognized a loss for the 1% discount at the time of sale, which is included in Other operating and administrative costs and expenses and in Net cash provided by operating activities in our condensed consolidated financial statements.
Under the revolving sales structure, BFC purchased receivables for cash on a daily basis from BHRS. When BFC ceased its purchases on March 1, 2004, accounts receivable began to increase on our condensed consolidated balance sheet. These Medicaid and VA receivables were collected by BHRS from the respective agencies and relieved from the aging as collected. Our cash flows from operating activities in 2004 have temporarily been negatively impacted since the timing of collections of these receivables is longer than when the receivables were being sold to BFC daily.
Revenues |
Our revenues are derived primarily from providing long-term healthcare services. Approximately 80% of our revenues for each of the three-month and nine-month periods ended September 30, 2004 and 2003 were derived from federal and state medical assistance programs (primarily Medicare and Medicaid). We record revenues when services are provided at standard charges adjusted to amounts estimated to be received under governmental programs and other third-party contractual arrangements based on contractual terms and historical experience. These revenues are reported at their estimated net realizable amounts and are subject to audit and retroactive adjustment.
Retroactive adjustments are estimated in the recording of revenues in the period the related services are rendered. These amounts are adjusted in future periods as adjustments become known or as cost reporting years are no longer subject to audits, reviews or investigations. Due to the complexity of the laws and
8
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 1. | General (Continued) |
regulations governing the Medicare and Medicaid programs, there is at least a possibility that recorded estimates will change by a material amount in the near term. Changes in estimates related to third party receivables resulted in an increase in revenues of $3.2 million and $4.6 million for the three months ended September 30, 2004 and 2003, respectively, and $8.3 million and $6.7 million for the nine months ended September 30, 2004 and 2003, respectively. We believe adequate provision has been made to reflect any adjustments that could result from audits of cost reports.
Compliance with laws and regulations governing the Medicare and Medicaid programs is subject to government review and interpretation, as well as significant regulatory action including fines, penalties, and possible exclusion from the Medicare and Medicaid programs. In addition, under the Medicare program, if the federal government makes a formal demand for reimbursement, even related to contested items, payment must be made for those items before the provider is given an opportunity to appeal and resolve the issue.
Comprehensive Income |
Comprehensive income includes charges and credits to stockholders equity not included in net income. Comprehensive income, net of income taxes, in 2003 consisted of unrealized gains on an available-for-sale security of $2.8 million and $3.5 million for the three-month and nine-month periods, respectively. Due to the sale of this security in the fourth quarter of 2003, comprehensive income equaled net income for the three-month and nine-month periods ended September 30, 2004. There was no accumulated other comprehensive income at September 30, 2004 or December 31, 2003.
Earnings Per Share |
The following table sets forth the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||||
September 30, | September 30, | |||||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||||
Numerator:
|
||||||||||||||||||
Numerator for basic and diluted net income per
share
|
$ | 24,400 | $ | 9,983 | $ | 21,916 | $ | 39,662 | ||||||||||
Denominator:
|
||||||||||||||||||
Denominator for basic net income per
share weighted average shares
|
108,039 | 107,142 | 107,613 | 106,356 | ||||||||||||||
Effect of dilutive securities:
|
||||||||||||||||||
Employee stock options
|
1,022 | 458 | 1,060 | 154 | ||||||||||||||
Denominator for diluted net income per
share weighted average shares and assumed
conversions
|
109,061 | 107,600 | 108,673 | 106,510 | ||||||||||||||
Basic net income per share
|
$ | 0.23 | $ | 0.09 | $ | 0.20 | $ | 0.37 | ||||||||||
Diluted net income per share
|
$ | 0.22 | $ | 0.09 | $ | 0.20 | $ | 0.37 | ||||||||||
9
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 1. | General (Continued) |
Diluted earnings per share does not include the impact of approximately 1.8 million and 6.9 million of employee stock options outstanding for the three-month and nine-month periods ended September 30, 2004 and 2003, respectively, because their effect would have been antidilutive.
Our $115.0 million of 2.75% convertible notes (the Convertible Notes) are convertible into shares of our common stock at an initial conversion price of $7.45 per share, at the option of the holder, when certain conditions are met prior to maturity. As of September 30, 2004, none of the conversion conditions had been met and, therefore, the common shares into which the Convertible Notes may be converted were not included in the calculation of our diluted earnings per share.
The Financial Accounting Standards Board (FASB) has ratified Emerging Issues Task Force (EITF) No. 04-8, The Effect of Contingently Convertible Debt on Diluted Earnings per Share, requiring contingently convertible debt instruments to be included in diluted earnings per share computations, if their effect is dilutive, regardless of whether the conversion trigger has been met. EITF 04-8 will be effective for reporting periods ending after December 15, 2004, and will require restatement of prior period earnings per share amounts presented for comparative purposes. Assuming the Convertible Notes had been included in our diluted per share calculation, our unaudited pro forma diluted net income per share for the three-month period ended September 30, 2004, would have been reduced by $.02 to $.20 per share diluted, based on a total number of shares outstanding of approximately 124,493,000. Per share amounts for the nine-month period ended September 30, 2004 would not have changed.
Note 2. | Insurance |
We believe that adequate provision has been made in the financial statements for liabilities that may arise out of patient care, and related services provided to date, as well as workers compensation. These provisions are based primarily upon the results of independent actuarial valuations, prepared by actuaries with healthcare industry experience. These independent valuations are formally prepared twice a year using the most recent trends of claims, settlements and other relevant data. In addition to the actuarial estimate of retained losses, our provision for insurance includes accruals for insurance premiums and related costs for the coverage period
10
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 2. | Insurance (Continued) |
and our estimate of any experience adjustments to premiums. The following table summarizes our provision for insurance and related items (in thousands):
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30, | September 30, | ||||||||||||||||
2004 | 2003 | 2004 | 2003 | ||||||||||||||
General and professional liability:
|
|||||||||||||||||
Continuing operations
|
$ | 15,422 | $ | 14,567 | $ | 51,764 | $ | 41,223 | |||||||||
Discontinued operations
|
1,171 | 6,069 | 12,074 | $ | 45,468 | (a) | |||||||||||
$ | 16,593 | $ | 20,636 | $ | 63,838 | $ | 86,691 | ||||||||||
Workers compensation:
|
|||||||||||||||||
Continuing operations
|
$ | 10,759 | $ | 9,894 | $ | 28,883 | $ | 30,710 | |||||||||
Discontinued operations
|
615 | 2,879 | 2,530 | 9,580 | |||||||||||||
$ | 11,374 | $ | 12,773 | $ | 31,413 | $ | 40,290 | ||||||||||
Other insurance:
|
|||||||||||||||||
Continuing operations
|
$ | 3,226 | $ | 3,431 | $ | 9,734 | $ | 10,232 | |||||||||
Discontinued operations
|
57 | 213 | 245 | 736 | |||||||||||||
$ | 3,283 | $ | 3,644 | $ | 9,979 | $ | 10,968 | ||||||||||
Total provision for insurance and related
items:
|
|||||||||||||||||
Continuing operations
|
$ | 29,407 | $ | 27,892 | $ | 90,381 | $ | 82,165 | |||||||||
Discontinued operations
|
1,843 | 9,161 | 14,849 | 55,784 | (a) | ||||||||||||
$ | 31,250 | $ | 37,053 | $ | 105,230 | $ | 137,949 | ||||||||||
(a) | Includes an accrual in 2003 for the purchase of incremental patient care liability insurance on disposed nursing facilities. |
Our insurance liabilities are included in the consolidated balance sheet captions as follows (in thousands):
September 30, | December 31, | ||||||||
2004 | 2003 | ||||||||
Current liabilities:
|
|||||||||
Accrued wages and related liabilities
|
$ | 488 | $ | 2,528 | |||||
General and professional liabilities
|
63,422 | 93,736 | |||||||
Other accrued liabilities
|
| 10,678 | |||||||
Long-term liabilities:
|
|||||||||
Other liabilities and deferred items
|
89,769 | 52,954 | |||||||
$ | 153,679 | $ | 159,896 | ||||||
During the nine months ended September 30, 2004, we reclassified a portion of our current general and professional liabilities to long-term, primarily due to aggregate limits being reached for certain prior policy
11
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 2. | Insurance (Continued) |
years and adjustments in actuarially projected claim payments for the next twelve months. The decrease in Other accrued liabilities resulted from a scheduled payment under the terms of a prior year workers compensation insurance policy.
Note 3. | Asset Impairments, Workforce Reductions and Other Unusual Items |
We recorded pre-tax charges (credits) for asset impairments, workforce reductions and other unusual items as follows (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
Asset impairments
|
$ | | $ | 972 | $ | 2,885 | $ | 1,010 | ||||||||
Workforce reductions
|
(1 | ) | 50 | 97 | 1,491 | |||||||||||
Exit costs and other unusual items
|
(237 | ) | 321 | (95 | ) | 618 | ||||||||||
Reversal of previously recorded charges
|
(375 | ) | | (1,699 | ) | (447 | ) | |||||||||
$ | (613 | ) | $ | 1,343 | $ | 1,188 | $ | 2,672 | ||||||||
Asset Impairments |
During the nine-month period ended September 30, 2004, we recorded asset impairments of $2.9 million primarily related to the write-down of property and equipment on two nursing facilities included in the Nursing Facilities segment. During the first quarter of 2004, management made a determination to close these nursing facilities, which led to an impairment assessment. We estimated the fair market values of these facilities based on salvage values for the land and buildings.
Workforce Reductions |
During the nine-month period ended September 30, 2004, we recorded $443,000 for workforce reductions, partially offset by $346,000 primarily due to the cancellation of restricted stock. The $443,000 for workforce reductions primarily related to 35 associates who were notified in 2004 that their positions would be eliminated and included $401,000 of cash expenses, $266,000 of which was paid during the nine months ended September 30, 2004.
During the nine-month period ended September 30, 2003, we recorded $1.5 million for workforce reductions primarily related to 43 associates who were notified in 2003 that their positions would be eliminated, including the following:
| $1.8 million of cash expenses, approximately $1.6 million of which was paid during the nine months ended September 30, 2003, with the remaining amount being paid during the year ended December 31, 2003; and | |
| non-cash expenses of approximately $125,000 related to the vesting of restricted stock, less approximately $400,000 due to related cancellations of restricted stock. |
12
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 3. | Asset Impairments, Workforce Reductions and Other Unusual Items (Continued) |
Other Unusual Items |
During the nine-month period ended September 30, 2004, we recorded an adjustment of $1.3 million resulting from the sale of a previously impaired foreign investment above the carrying value and recorded an adjustment of $375,000 to our Florida disposition costs as a result of collecting a note receivable, received as partial payment for this transaction, above the carrying value. During the nine months ended September 30, 2003, we recorded special pre-tax charges of $618,000 for certain other unusual items and exit costs for retention and severance agreements with employees associated with facilities affected by our divestiture strategy. We also recorded an adjustment of $447,000 primarily resulting from the settlement of a previously impaired asset at a price above the carrying value. The following table summarizes activity in our accruals for estimated workforce reductions and exit costs (in thousands):
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||||||||||||||||||
Workforce | Workforce | Workforce | Workforce | |||||||||||||||||||||||||||||
Reductions | Exit Costs | Reductions | Exit Costs | Reductions | Exit Costs | Reductions | Exit Costs | |||||||||||||||||||||||||
Balance beginning of period
|
$ | 1,535 | $ | 6,667 | $ | 2,737 | $ | 5,325 | $ | 3,029 | $ | 7,270 | $ | 5,418 | $ | 4,991 | ||||||||||||||||
Charged to continuing operations
|
126 | (237 | ) | 202 | 2,886 | 553 | 10 | 1,643 | 2,910 | |||||||||||||||||||||||
Charged to discontinued operations
|
| 232 | | 12,033 | | 3,032 | | 13,772 | ||||||||||||||||||||||||
Cash payments
|
(364 | ) | (1,649 | ) | (356 | ) | (9,938 | ) | (2,302 | ) | (5,299 | ) | (4,637 | ) | (11,401 | ) | ||||||||||||||||
Stock transactions
|
| | | | | | 84 | | ||||||||||||||||||||||||
Adjustments
|
(127 | ) | | (152 | ) | | (110 | ) | | (77 | ) | 34 | ||||||||||||||||||||
Balance end of period
|
$ | 1,170 | $ | 5,013 | $ | 2,431 | $ | 10,306 | $ | 1,170 | $ | 5,013 | $ | 2,431 | $ | 10,306 | ||||||||||||||||
Workforce reduction and exit cost accruals are included in Accrued wages and related liabilities and Other accrued liabilities on our condensed consolidated balance sheets.
Note 4. | Discontinued Operations |
During the nine months ended September 30, 2004, we recognized net pre-tax losses of $290,000 relating to the following 2004 disposal activities:
| 15 nursing facilities (1,703 beds) and one assisted living center (32 units) in our Nursing Facilities segment for cash proceeds totaling $9.2 million; and | |
| a home medical equipment business in our Home Care segment for cash proceeds totaling $370,000. |
We have included the remaining assets and liabilities of our former Matrix segment, as well as the assets of 24 nursing facilities (2,306 beds) of our Nursing Facilities segment, as held for sale in the accompanying condensed consolidated balance sheet as of September 30, 2004. The remaining assets and liabilities of our former Matrix segment were included in assets and liabilities held for sale as of December 31, 2003. Long-lived assets classified as held-for-sale were initially measured at the lower of carrying value or fair value less costs to sell. We reassess the fair value less costs to sell of the held-for-sale assets each reporting period. A divestiture plan for these groups of assets has been approved by our Board of Directors and we expect to dispose of these groups in the next three to nine months.
13
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 4. | Discontinued Operations (Continued) |
A summary by operating segment of the asset and liability line items from which the reclassifications have been made at September 30, 2004 and December 31, 2003 is as follows (in thousands):
2004 | |||||||||||||||||
2003 | |||||||||||||||||
Nursing | Matrix | Total | Matrix | ||||||||||||||
Current assets
|
$ | 512 | $ | 2,035 | $ | 2,547 | $ | 2,042 | |||||||||
Property and equipment, net
|
10,774 | 1,208 | 11,982 | 1,100 | |||||||||||||
Goodwill
|
| 332 | 332 | 332 | |||||||||||||
Other assets
|
239 | 28 | 267 | 24 | |||||||||||||
Total assets held for sale
|
$ | 11,525 | $ | 3,603 | $ | 15,128 | $ | 3,498 | |||||||||
Current liabilities held for sale
|
$ | | $ | 622 | $ | 622 | $ | 672 | |||||||||
The results of operations of disposed facilities and other assets in the three-month and nine-month periods ended September 30, 2004, as well as the results of operations of held-for-sale assets, have been reported as discontinued operations for all periods presented in the accompanying condensed consolidated statements of income. Also included in discontinued operations are the gains and losses on sales and exit costs relative to these transactions. In addition, discontinued operations for the three-month and nine-month periods ended September 30, 2003 include the results of operations for all facilities, clinics and businesses disposed of during 2003. A summary of discontinued operations by operating segment is as follows (in thousands):
2004 | 2003 | |||||||||||||||||||||||||||||||
Home | Nursing | Home | Nursing | |||||||||||||||||||||||||||||
Matrix | Care | Facilities | Total | Matrix | Care | Facilities | Total | |||||||||||||||||||||||||
Three Months Ended September 30
|
||||||||||||||||||||||||||||||||
Revenues
|
$ | 3,563 | $ | | $ | 29,599 | $ | 33,162 | $ | 3,314 | $ | 2,539 | $ | 115,773 | $ | 121,626 | ||||||||||||||||
Operating income (loss)(a)
|
$ | 211 | $ | 33 | $ | 2,075 | $ | 2,319 | $ | 228 | $ | (1,099 | ) | $ | (2,681 | ) | $ | (3,552 | ) | |||||||||||||
Gain (loss) on sales and exit costs
|
(24 | ) | 366 | 472 | 814 | | 309 | 6,871 | 7,180 | |||||||||||||||||||||||
Impairments and other unusual items
|
| | 51 | 51 | | | (1,698 | ) | (1,698 | ) | ||||||||||||||||||||||
Pre-tax income (loss)
|
$ | 187 | $ | 399 | $ | 2,598 | 3,184 | $ | 228 | $ | (790 | ) | $ | 2,492 | 1,930 | |||||||||||||||||
Benefit from income taxes
|
(59 | ) | | |||||||||||||||||||||||||||||
Discontinued operations, net of taxes
|
$ | 3,243 | $ | 1,930 | ||||||||||||||||||||||||||||
(a) | Includes net interest expense of $8,000 and $576,000 and depreciation and amortization of $29,000 and $2.3 million for 2004 and 2003, respectively. |
14
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 4. | Discontinued Operations (Continued) |
2004 | 2003 | |||||||||||||||||||||||||||||||
Home | Nursing | Home | Nursing | |||||||||||||||||||||||||||||
Matrix | Care | Facilities | Total | Matrix | Care | Facilities | Total | |||||||||||||||||||||||||
Nine Months Ended September 30
|
||||||||||||||||||||||||||||||||
Revenues
|
$ | 10,466 | $ | 148 | $ | 115,348 | $ | 125,962 | $ | 14,847 | $ | 20,184 | $ | 421,607 | $ | 456,638 | ||||||||||||||||
Operating income (loss)(a)
|
$ | 859 | $ | 1 | $ | (2,319 | ) | $ | (1,459 | ) | $ | 336 | $ | (2,092 | ) | $ | (1,002 | ) | $ | (2,758 | ) | |||||||||||
Gain (loss) on sales and exit costs
|
(49 | ) | 369 | (610 | ) | (290 | ) | 10,940 | 929 | 34,691 | 46,560 | |||||||||||||||||||||
Impairments and other unusual items(b)
|
| | (2,855 | ) | (2,855 | ) | | (540 | ) | (18,828 | ) | (19,368 | ) | |||||||||||||||||||
Pre-tax income (loss)
|
$ | 810 | $ | 370 | $ | (5,784 | ) | (4,604 | ) | $ | 11,276 | $ | (1,703 | ) | $ | 14,861 | 24,434 | |||||||||||||||
Provision for income taxes
|
286 | | ||||||||||||||||||||||||||||||
Discontinued operations, net of taxes
|
$ | (4,890 | ) | $ | 24,434 | |||||||||||||||||||||||||||
(a) | Includes net interest expense of $158,000 and $2.7 million and depreciation and amortization of $1.4 million and $9.2 million for 2004 and 2003, respectively. | |
(b) | Includes an accrual in 2003 for the purchase of incremental patient care liability insurance on disposed nursing facilities. |
Note 5. | Acquisitions and Dispositions |
On July 30, 2004, we purchased substantially all of the assets of Hospice USA, LLC and its affiliates, which were privately held companies providing hospice services in Mississippi, Alabama and Tennessee, for cash of approximately $69.1 million. At the time of acquisition, Hospice USA, LLC and its affiliates operated 18 hospice locations and had an additional 16 locations under development.
The acquisition was part of our ongoing strategy to expand our service businesses. The purchase price allocation is preliminary and further adjustments may be made based on a working capital settlement to be finalized during the fourth quarter of 2004. We allocated the purchase price based on estimated fair values. Goodwill related to the Hospice, USA acquisition was $68.0 million as of September 30, 2004.
The unaudited pro forma condensed statements of income for the three-month and nine-month periods ended September 30, 2004 and 2003 have been prepared as if the acquisition had taken place on January 1, 2003. The following table summarizes our unaudited pro forma information (in thousands, except per share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
Revenues
|
$ | 511,116 | $ | 469,892 | $ | 1,505,079 | $ | 1,367,128 | ||||||||
Income before discontinued operations
|
21,657 | 9,105 | 29,579 | 20,012 | ||||||||||||
Income per share before discontinued operations
|
0.20 | 0.09 | 0.27 | 0.19 | ||||||||||||
Net income
|
24,900 | 11,035 | 24,689 | 44,446 | ||||||||||||
Net income per share
|
0.23 | 0.10 | 0.23 | 0.42 |
15
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 5. | Acquisitions and Dispositions (Continued) |
During the nine months ended September 30, 2004, we sold an additional four nursing facilities (639 beds), and certain other assets for cash proceeds of $11.4 million and closed two nursing facilities (182 beds) and one assisted living center (9 units). We did not operate three of the nursing facilities sold, which were previously leased to another nursing home operator. We recognized net pre-tax gains of $614,000, included in Net gains on dispositions on the condensed consolidated statements of income, as a result of these disposal activities. These dispositions did not meet the criteria in Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (SFAS No. 144) to be included in discontinued operations.
Note 6. | Long-Term Debt |
On October 6, 2004, we entered into a $40.0 million letter of credit facility (the LOC facility) maturing in October 2008. The LOC facility is secured by certain of our Medicaid and Veterans Administration accounts receivable and contains standard terms and conditions, including a 2.375% fee on outstanding letters of credit. It is our intent to transfer the letters of credit currently under our revolving credit facility to the LOC facility, thereby freeing up the $90.0 million revolving credit facility for future borrowing.
During June 2004, we commenced a cash tender offer to purchase any and all of our $200.0 million 9 5/8% senior notes due 2009 at an offer price of $1,190 per $1,000 principal amount tendered, plus accrued and unpaid interest, and a solicitation of consents to amend the indenture under which the 9 5/8% senior notes were issued. Holders of $190.6 million of the 9 5/8% senior notes had tendered their notes and delivered consents prior to the July 9, 2004 expiration of the tender offer.
During June 2004, we issued $215.0 million of 7 7/8% senior subordinated notes due June 15, 2014 (the Senior Subordinated Notes). The Senior Subordinated Notes were issued at a discount (98.318% of par) to yield 8.125%. The Senior Subordinated Notes are general unsecured obligations subordinated in right of payment to our existing and future senior unsubordinated indebtedness and are guaranteed by certain of our subsidiaries. The Senior Subordinated Notes were issued through a private placement. We filed a registration statement with the SEC on September 23, 2004, in order to affect an exchange offer of these notes for publicly tradable notes. The proceeds from the Senior Subordinated Notes, together with cash on hand, were used to purchase for cash $190.6 million of our 9 5/8% senior notes tendered, as well as to pay related fees and expenses. We recorded a pre-tax charge of $40.4 million related to this transaction, including $36.1 million for the prepayment premium and $3.7 million for the write-off of deferred financing costs on the 9 5/8% senior notes, as well as $681,000 for fees and expenses related to the cash tender offer.
During the second quarter of 2004, we entered into two amendments to our senior credit facility which, among other things, permitted the issuance of the Senior Subordinated Notes and the purchase of our 9 5/8% senior notes, reduced the interest rate on the term loan portion of the senior credit facility, increased the size of our revolving credit facility from $75.0 million to $90.0 million and modified certain financial covenant levels.
16
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information |
Our 7 7/8% senior subordinated notes are jointly and severally, fully and unconditionally guaranteed by most of our subsidiaries. As of September 30, 2004, the non-guarantor subsidiaries included Beverly Indemnity, Ltd., our captive insurance subsidiary, and Beverly Funding Corporation, our receivables-backed financing subsidiary. Since the carrying value of the assets of the non-guarantor subsidiaries exceeds three percent of the consolidated assets of Beverly Enterprises, Inc., we are required to disclose consolidating financial statements in our periodic filings with the SEC. Condensed consolidating balance sheets as of September 30, 2004 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | ||||||||||||||||||||||
Guarantor | Guarantor | |||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | ||||||||||||||||||
ASSETS | ||||||||||||||||||||||
Current assets:
|
||||||||||||||||||||||
Cash and cash equivalents
|
$ | 144,845 | $ | 6,599 | $ | 55,916 | $ | | $ | 207,360 | ||||||||||||
Accounts receivable, less allowance for doubtful
|
6,398 | 200,975 | 7,965 | | 215,338 | |||||||||||||||||
Notes receivable, less allowance for doubtful
notes
|
18 | 6,481 | | | 6,499 | |||||||||||||||||
Operating supplies
|
108 | 9,142 | | | 9,250 | |||||||||||||||||
Assets held for sale
|
| 15,128 | | | 15,128 | |||||||||||||||||
Prepaid expenses and other
|
12,806 | 10,449 | 15,880 | | 39,135 | |||||||||||||||||
Total current assets
|
164,175 | 248,774 | 79,761 | | 492,710 | |||||||||||||||||
Property and equipment, net
|
5,982 | 640,878 | | | 646,860 | |||||||||||||||||
Other assets:
|
||||||||||||||||||||||
Goodwill, net
|
| 124,467 | | | 124,467 | |||||||||||||||||
Other, less allowance for doubtful accounts and
notes
|
169,622 | 35,421 | 161 | (134,569 | ) | 70,635 | ||||||||||||||||
Due from affiliates
|
517,684 | | 116,931 | (634,615 | ) | | ||||||||||||||||
Total other assets
|
687,306 | 159,888 | 117,092 | (769,184 | ) | 195,102 | ||||||||||||||||
$ | 857,463 | $ | 1,049,540 | $ | 196,853 | $ | (769,184 | ) | $ | 1,334,672 | ||||||||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||||||||||||||
Current liabilities:
|
||||||||||||||||||||||
Accounts payable
|
$ | 4,964 | $ | 54,117 | $ | | $ | | $ | 59,081 | ||||||||||||
Accrued wages and related liabilities
|
21,928 | 73,550 | | | 95,478 | |||||||||||||||||
Accrued interest
|
7,780 | 1,286 | | | 9,066 | |||||||||||||||||
General and professional liabilities
|
20,981 | | 46,065 | (3,624 | ) | 63,422 | ||||||||||||||||
Federal government settlement obligations
|
| 14,064 | | | 14,064 | |||||||||||||||||
Liabilities held for sale
|
| 622 | | | 622 | |||||||||||||||||
Other accrued liabilities
|
15,220 | 71,923 | | | 87,143 | |||||||||||||||||
Current portion of long-term debt
|
1,350 | 10,294 | | | 11,644 | |||||||||||||||||
Total current liabilities
|
72,223 | 225,856 | 46,065 | (3,624 | ) | 340,520 | ||||||||||||||||
Long-term debt
|
468,134 | 90,354 | | | 558,488 | |||||||||||||||||
Other liabilities and deferred items
|
55,413 | 62,257 | 56,301 | | 173,971 | |||||||||||||||||
Due to affiliates
|
| 634,615 | | (634,615 | ) | | ||||||||||||||||
Commitments and contingencies
|
||||||||||||||||||||||
Stockholders equity:
|
||||||||||||||||||||||
Preferred stock, shares authorized
|
| | | | | |||||||||||||||||
Common stock, shares issued
|
11,624 | 5,908 | 120 | (6,028 | ) | 11,624 | ||||||||||||||||
Additional paid-in capital
|
897,476 | 357,472 | 7,556 | (365,028 | ) | 897,476 | ||||||||||||||||
Retained earnings (accumulated deficit)
|
(538,909 | ) | (326,922 | ) | 86,811 | 240,111 | (538,909 | ) | ||||||||||||||
Treasury stock, at cost
|
(108,498 | ) | | | | (108,498 | ) | |||||||||||||||
Total stockholders equity
|
261,693 | 36,458 | 94,487 | (130,945 | ) | 261,693 | ||||||||||||||||
$ | 857,463 | $ | 1,049,540 | $ | 196,853 | $ | (769,184 | ) | $ | 1,334,672 | ||||||||||||
17
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating balance sheets as of December 31, 2003 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | ||||||||||||||||||||||
Guarantor | Guarantor | |||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | ||||||||||||||||||
ASSETS | ||||||||||||||||||||||
Current assets:
|
||||||||||||||||||||||
Cash and cash equivalents
|
$ | 223,575 | $ | 5,351 | $ | 29,889 | $ | | $ | 258,815 | ||||||||||||
Accounts receivable patient, less
allowance for doubtful accounts
|
| 149,108 | | | 149,108 | |||||||||||||||||
Accounts receivable non-patient, less
allowance for doubtful accounts
|
2,481 | 4,445 | 8,601 | | 15,527 | |||||||||||||||||
Notes receivable, less allowance for doubtful
notes
|
18 | 13,706 | | | 13,724 | |||||||||||||||||
Operating supplies
|
47 | 10,378 | | | 10,425 | |||||||||||||||||
Assets held for sale
|
| 3,498 | | | 3,498 | |||||||||||||||||
Investment in Beverly Funding Corporation
|
31,342 | | | | 31,342 | |||||||||||||||||
Prepaid expenses and other
|
10,964 | 10,604 | 11,809 | | 33,377 | |||||||||||||||||
Total current assets
|
268,427 | 197,090 | 50,299 | | 515,816 | |||||||||||||||||
Property and equipment, net
|
7,134 | 687,086 | | | 694,220 | |||||||||||||||||
Other assets:
|
||||||||||||||||||||||
Goodwill, net
|
| 57,102 | | | 57,102 | |||||||||||||||||
Other, less allowance for doubtful accounts and
notes
|
121,031 | 45,446 | | (87,194 | ) | 79,283 | ||||||||||||||||
Due from affiliates
|
421,828 | | 145,240 | (567,068 | ) | | ||||||||||||||||
Total other assets
|
542,859 | 102,548 | 145,240 | (654,262 | ) | 136,385 | ||||||||||||||||
$ | 818,420 | $ | 986,724 | $ | 195,539 | $ | (654,262 | ) | $ | 1,346,421 | ||||||||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||||||||||||||
Current liabilities:
|
||||||||||||||||||||||
Accounts payable
|
$ | 8,123 | $ | 59,449 | $ | | $ | | $ | 67,572 | ||||||||||||
Accrued wages and related liabilities
|
25,104 | 91,613 | | | 116,717 | |||||||||||||||||
Accrued interest
|
5,733 | 1,163 | | | 6,896 | |||||||||||||||||
General and professional liabilities
|
41,370 | | 70,425 | (18,059 | ) | 93,736 | ||||||||||||||||
Federal government settlement obligations
|
| 13,125 | | | 13,125 | |||||||||||||||||
Liabilities held for sale
|
| 672 | | | 672 | |||||||||||||||||
Other accrued liabilities
|
16,502 | 85,787 | | | 102,289 | |||||||||||||||||
Current portion of long-term debt
|
1,350 | 12,004 | | | 13,354 | |||||||||||||||||
Total current liabilities
|
98,182 | 263,813 | 70,425 | (18,059 | ) | 414,361 | ||||||||||||||||
Long-term debt
|
448,313 | 104,560 | | | 552,873 | |||||||||||||||||
Other liabilities and deferred items
|
33,739 | 69,342 | 37,920 | | 141,001 | |||||||||||||||||
Due to affiliates
|
| 567,068 | | (567,068 | ) | | ||||||||||||||||
Commitments and contingencies
|
||||||||||||||||||||||
Stockholders equity:
|
||||||||||||||||||||||
Preferred stock, shares authorized
|
| | | | | |||||||||||||||||
Common stock, shares issued
|
11,559 | 5,908 | 120 | (6,028 | ) | 11,559 | ||||||||||||||||
Additional paid-in capital
|
895,950 | 364,609 | 7,556 | (372,165 | ) | 895,950 | ||||||||||||||||
Retained earnings (accumulated deficit)
|
(560,825 | ) | (388,576 | ) | 79,518 | 309,058 | (560,825 | ) | ||||||||||||||
Treasury stock, at cost
|
(108,498 | ) | | | | (108,498 | ) | |||||||||||||||
Total stockholders equity
|
238,186 | (18,059 | ) | 87,194 | (69,135 | ) | 238,186 | |||||||||||||||
$ | 818,420 | $ | 986,724 | $ | 195,539 | $ | (654,262 | ) | $ | 1,346,421 | ||||||||||||
18
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of income for the three months ended September 30, 2004 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | |||||||||||||||||||||||
Guarantor | Guarantor | ||||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | |||||||||||||||||||
Revenues
|
$ | 1,693 | $ | 506,686 | $ | 13,805 | $ | (14,015 | ) | $ | 508,169 | ||||||||||||
Costs and expenses:
|
|||||||||||||||||||||||
Wages and related
|
14,417 | 286,317 | | | 300,734 | ||||||||||||||||||
Provision for insurance and related items
|
2,407 | 27,000 | 15,103 | (15,103 | ) | 29,407 | |||||||||||||||||
Other operating and administrative
|
7,861 | 123,948 | (235 | ) | (14 | ) | 131,560 | ||||||||||||||||
Overhead allocation
|
(20,189 | ) | 20,189 | | | | |||||||||||||||||
Depreciation and amortization
|
1,617 | 14,301 | | | 15,918 | ||||||||||||||||||
Asset impairments, workforce reductions and other
unusual items
|
1,421 | (2,034 | ) | | | (613 | ) | ||||||||||||||||
Total costs and expenses
|
7,534 | 469,721 | 14,868 | (15,117 | ) | 477,006 | |||||||||||||||||
Income (loss) before other income (expenses)
|
(5,841 | ) | 36,965 | (1,063 | ) | 1,102 | 31,163 | ||||||||||||||||
Other income (expenses):
|
|||||||||||||||||||||||
Interest expense
|
| (12,216 | ) | | 1,094 | (11,122 | ) | ||||||||||||||||
Costs related to early extinguishments of debt
|
(176 | ) | | | | (176 | ) | ||||||||||||||||
Interest income
|
527 | 452 | 1,361 | (1,094 | ) | 1,246 | |||||||||||||||||
Net gains on dispositions
|
| 582 | | | 582 | ||||||||||||||||||
Equity in earnings (or losses) of affiliates
|
30,426 | | | (30,426 | ) | | |||||||||||||||||
Total other expenses, net
|
30,777 | (11,182 | ) | 1,361 | (30,426 | ) | (9,470 | ) | |||||||||||||||
Income (loss) before provision for income taxes
and discontinued operations
|
24,936 | 25,783 | 298 | (29,324 | ) | 21,693 | |||||||||||||||||
Provision for income taxes
|
536 | | | | 536 | ||||||||||||||||||
Income (loss) before discontinued operations
|
24,400 | 25,783 | 298 | (29,324 | ) | 21,157 | |||||||||||||||||
Discontinued operations, net of taxes
|
| 3,243 | | | 3,243 | ||||||||||||||||||
Net income (loss)
|
$ | 24,400 | $ | 29,026 | $ | 298 | $ | (29,324 | ) | $ | 24,400 | ||||||||||||
19
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of income for the three months ended September 30, 2003 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | |||||||||||||||||||||||
Guarantor | Guarantor | ||||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | |||||||||||||||||||
Revenues
|
$ | 19 | $ | 461,182 | $ | 1,343 | $ | (1,343 | ) | $ | 461,201 | ||||||||||||
Costs and expenses:
|
|||||||||||||||||||||||
Wages and related
|
14,177 | 261,745 | | | 275,922 | ||||||||||||||||||
Provision for insurance and related items
|
2,659 | 25,233 | 3,743 | (3,743 | ) | 27,892 | |||||||||||||||||
Other operating and administrative
|
5,073 | 111,425 | | | 116,498 | ||||||||||||||||||
Overhead allocation
|
(21,193 | ) | 21,193 | | | | |||||||||||||||||
Depreciation and amortization
|
1,740 | 13,043 | | | 14,783 | ||||||||||||||||||
Asset impairments, workforce reductions and other
unusual items
|
253 | 1,090 | | | 1,343 | ||||||||||||||||||
Total costs and expenses
|
2,709 | 433,729 | 3,743 | (3,743 | ) | 436,438 | |||||||||||||||||
Income (loss) before other income (expenses)
|
(2,690 | ) | 27,453 | (2,400 | ) | 2,400 | 24,763 | ||||||||||||||||
Other income (expenses):
|
|||||||||||||||||||||||
Interest expense
|
| (17,506 | ) | | 1,477 | (16,029 | ) | ||||||||||||||||
Interest income
|
306 | 723 | 1,618 | (1,477 | ) | 1,170 | |||||||||||||||||
Net gains on dispositions
|
| 2 | | | 2 | ||||||||||||||||||
Equity in earnings (or losses) of affiliates
|
14,220 | | | (14,220 | ) | | |||||||||||||||||
Total other expenses, net
|
14,526 | (16,781 | ) | 1,618 | (14,220 | ) | (14,857 | ) | |||||||||||||||
Income (loss) before provision for income taxes
and discontinued operations
|
11,836 | 10,672 | (782 | ) | (11,820 | ) | 9,906 | ||||||||||||||||
Provision for income taxes
|
1,853 | | | | 1,853 | ||||||||||||||||||
Income (loss) before discontinued operations
|
9,983 | 10,672 | (782 | ) | (11,820 | ) | 8,053 | ||||||||||||||||
Discontinued operations, net of taxes
|
| 1,930 | | | 1,930 | ||||||||||||||||||
Net income (loss)
|
$ | 9,983 | $ | 12,602 | $ | (782 | ) | $ | (11,820 | ) | $ | 9,983 | |||||||||||
20
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of income for the nine months ended September 30, 2004 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | |||||||||||||||||||||||
Guarantor | Guarantor | ||||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | |||||||||||||||||||
Revenues
|
$ | 2,907 | $ | 1,483,607 | $ | 57,011 | $ | (57,221 | ) | $ | 1,486,304 | ||||||||||||
Costs and expenses:
|
|||||||||||||||||||||||
Wages and related
|
33,847 | 822,559 | | | 856,406 | ||||||||||||||||||
Provision for insurance and related items
|
7,203 | 83,178 | 53,990 | (53,990 | ) | 90,381 | |||||||||||||||||
Other operating and administrative
|
19,805 | 371,893 | (235 | ) | (14 | ) | 391,449 | ||||||||||||||||
Overhead allocation
|
(60,962 | ) | 60,962 | | | | |||||||||||||||||
Depreciation and amortization
|
5,018 | 41,223 | | | 46,241 | ||||||||||||||||||
Asset impairments, workforce reductions and other
unusual items
|
97 | 1,091 | | | 1,188 | ||||||||||||||||||
Total costs and expenses
|
5,008 | 1,380,906 | 53,755 | (54,004 | ) | 1,385,665 | |||||||||||||||||
Income (loss) before other income (expenses)
|
(2,101 | ) | 102,701 | 3,256 | (3,217 | ) | 100,639 | ||||||||||||||||
Other income (expenses):
|
|||||||||||||||||||||||
Interest expense
|
| (38,502 | ) | | 3,434 | (35,068 | ) | ||||||||||||||||
Costs related to early extinguishments of debt
|
(40,430 | ) | | | | (40,430 | ) | ||||||||||||||||
Interest income
|
1,755 | 1,731 | 4,037 | (3,434 | ) | 4,089 | |||||||||||||||||
Net gains on dispositions
|
| 614 | | | 614 | ||||||||||||||||||
Equity in earnings (or losses) of affiliates
|
65,730 | | | (65,730 | ) | | |||||||||||||||||
Total other expenses, net
|
27,055 | (36,157 | ) | 4,037 | (65,730 | ) | (70,795 | ) | |||||||||||||||
Income (loss) before provision for income taxes
and discontinued operations
|
24,954 | 66,544 | 7,293 | (68,947 | ) | 29,844 | |||||||||||||||||
Provision for income taxes
|
3,038 | | | | 3,038 | ||||||||||||||||||
Income (loss) before discontinued operations
|
21,916 | 66,544 | 7,293 | (68,947 | ) | 26,806 | |||||||||||||||||
Discontinued operations, net of taxes
|
| (4,890 | ) | | | (4,890 | ) | ||||||||||||||||
Net income (loss)
|
$ | 21,916 | $ | 61,654 | $ | 7,293 | $ | (68,947 | ) | $ | 21,916 | ||||||||||||
21
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of income for the nine months ended September 30, 2003 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | |||||||||||||||||||||||
Guarantor | Guarantor | ||||||||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Eliminations | Total | |||||||||||||||||||
Revenues
|
$ | 10 | $ | 1,345,020 | $ | 10,495 | $ | (10,495 | ) | $ | 1,345,030 | ||||||||||||
Costs and expenses:
|
|||||||||||||||||||||||
Wages and related
|
39,462 | 767,827 | | | 807,289 | ||||||||||||||||||
Provision for insurance and related items
|
7,995 | 74,170 | 7,732 | (7,732 | ) | 82,165 | |||||||||||||||||
Other operating and administrative
|
18,832 | 328,037 | | | 346,869 | ||||||||||||||||||
Overhead allocation
|
(61,526 | ) | 61,526 | | | | |||||||||||||||||
Depreciation and amortization
|
5,141 | 38,493 | | | 43,634 | ||||||||||||||||||
Adjustment related to California investigation
settlement
|
| (925 | ) | | | (925 | ) | ||||||||||||||||
Asset impairments, workforce reductions and other
unusual items
|
1,419 | 1,253 | | | 2,672 | ||||||||||||||||||
Total costs and expenses
|
11,323 | 1,270,381 | 7,732 | (7,732 | ) | 1,281,704 | |||||||||||||||||
Income (loss) before other income (expenses)
|
(11,313 | ) | 74,639 | 2,763 | (2,763 | ) | 63,326 | ||||||||||||||||
Other income (expenses):
|
|||||||||||||||||||||||
Interest expense
|
| (53,254 | ) | | 5,493 | (47,761 | ) | ||||||||||||||||
Interest income
|
1,094 | 1,998 | 5,955 | (5,493 | ) | 3,554 | |||||||||||||||||
Net gains on dispositions
|
| 399 | | | 399 | ||||||||||||||||||
Equity in earnings (or losses) of affiliates
|
54,171 | | | (54,171 | ) | | |||||||||||||||||
Total other expenses, net
|
55,265 | (50,857 | ) | 5,955 | (54,171 | ) | (43,808 | ) | |||||||||||||||
Income (loss) before provision for income taxes
and discontinued operations
|
43,952 | 23,782 | 8,718 | (56,934 | ) | 19,518 | |||||||||||||||||
Provision for income taxes
|
4,290 | | | | 4,290 | ||||||||||||||||||
Income (loss) before discontinued operations
|
39,662 | 23,782 | 8,718 | (56,934 | ) | 15,228 | |||||||||||||||||
Discontinued operations, net of taxes
|
| 24,434 | | | 24,434 | ||||||||||||||||||
Net income (loss)
|
$ | 39,662 | $ | 48,216 | $ | 8,718 | $ | (56,934 | ) | $ | 39,662 | ||||||||||||
22
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of cash flows for the nine months ended September 30, 2004 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | ||||||||||||||||||
Guarantor | Guarantor | |||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Total | |||||||||||||||
Cash flows from operating activities:
|
$ | (72,473 | ) | $ | 84,115 | $ | 26,078 | $ | 37,720 | |||||||||
Cash flows from investing activities:
|
||||||||||||||||||
Capital expenditures
|
(3,912 | ) | (34,052 | ) | | (37,964 | ) | |||||||||||
Payments for acquisitions, net of cash acquired
|
| (71,479 | ) | | (71,479 | ) | ||||||||||||
Proceeds from dispositions of facilities and
other assets, net
|
1,324 | 21,022 | | 22,346 | ||||||||||||||
Proceeds from Beverly Funding Corporation
|
28,956 | | | 28,956 | ||||||||||||||
Collections on notes receivable
|
| 32,268 | | 32,268 | ||||||||||||||
Payments for designated funds, net
|
(230 | ) | (728 | ) | | (958 | ) | |||||||||||
Other, net
|
(10,446 | ) | (13,870 | ) | (24,316 | ) | ||||||||||||
Net cash provided by (used for) investing
activities
|
15,692 | (66,839 | ) | | (51,147 | ) | ||||||||||||
Cash flows from financing activities:
|
||||||||||||||||||
Repayments of long-term debt
|
(191,623 | ) | (15,856 | ) | | (207,479 | ) | |||||||||||
Repayments of off-balance sheet financing
|
| | | | ||||||||||||||
Proceeds from issuance of long-term debt
|
211,384 | | | 211,384 | ||||||||||||||
Proceeds from exercise of stock options
|
1,399 | | | 1,399 | ||||||||||||||
Deferred financing and other costs
|
(43,281 | ) | | (51 | ) | (43,332 | ) | |||||||||||
Net cash used for financing activities
|
(22,121 | ) | (15,856 | ) | (51 | ) | (38,028 | ) | ||||||||||
Net increase (decrease) in cash and cash
equivalents
|
(78,902 | ) | 1,420 | 26,027 | (51,455 | ) | ||||||||||||
Cash and cash equivalents at beginning of period
|
223,575 | 5,351 | 29,889 | 258,815 | ||||||||||||||
Cash and cash equivalents at end of period
|
$ | 144,673 | $ | 6,771 | $ | 55,916 | $ | 207,360 | ||||||||||
23
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 7. | Additional Guarantor Information (Continued) |
Condensed consolidating statements of cash flows for the nine months ended September 30, 2003 for Beverly Enterprises, Inc. (parent only), the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:
Non- | ||||||||||||||||||
Guarantor | Guarantor | |||||||||||||||||
Parent | Subsidiaries | Subsidiaries | Total | |||||||||||||||
Cash flows from operating activities:
|
$ | 47,554 | $ | (17,573 | ) | $ | 23,446 | $ | 53,427 | |||||||||
Cash flows from investing activities:
|
||||||||||||||||||
Capital expenditures
|
(4,493 | ) | (24,561 | ) | | (29,054 | ) | |||||||||||
Payments for acquisitions, net of cash acquired
|
| (404 | ) | | (404 | ) | ||||||||||||
Proceeds from dispositions of facilities and
other assets, net
|
| 173,102 | | 173,102 | ||||||||||||||
Proceeds from Beverly Funding Corporation
investment
|
| | | | ||||||||||||||
Collections on notes receivable
|
6 | 504 | | 510 | ||||||||||||||
Payments for designated funds, net
|
(5,711 | ) | 391 | | (5,320 | ) | ||||||||||||
Other, net
|
166 | (9,176 | ) | | (9,010 | ) | ||||||||||||
Net cash provided by (used for) investing
activities
|
(10,032 | ) | 139,856 | | 129,824 | |||||||||||||
Cash flows from financing activities:
|
||||||||||||||||||
Repayments of long-term debt
|
(1,813 | ) | (56,399 | ) | | (58,212 | ) | |||||||||||
Repayments of off-balance sheet financing
|
| (69,456 | ) | | (69,456 | ) | ||||||||||||
Proceeds from issuance of new debt
|
| | | | ||||||||||||||
Proceeds from exercise of stock options
|
98 | | | 98 | ||||||||||||||
Deferred financing and other costs
|
(2,399 | ) | (10 | ) | | (2,409 | ) | |||||||||||
Net cash used for financing activities
|
(4,114 | ) | (125,865 | ) | | (129,979 | ) | |||||||||||
Net increase (decrease) in cash and cash
equivalents
|
33,408 | (3,582 | ) | 23,446 | 53,272 | |||||||||||||
Cash and cash equivalents at beginning of period
|
86,456 | 8,516 | 20,473 | 115,445 | ||||||||||||||
Cash and cash equivalents at end of period
|
$ | 119,864 | $ | 4,934 | $ | 43,919 | $ | 168,717 | ||||||||||
Note 8. | Income Taxes |
The provisions for income taxes from continuing operations of $3.0 million and $4.3 million for the nine months ended September 30, 2004 and 2003, respectively, primarily relate to state income taxes. The tax provisions differ from those calculated using the federal statutory rate due to changes in the valuation allowance, established at December 31, 2001, for net deferred tax assets. In 2004, the valuation allowance decreased $19.5 million primarily due to the reversal of temporary differences and the utilization of net operating loss carryforwards to offset taxable income. In 2003, the valuation allowance decreased primarily due to the reversal of temporary differences in conjunction with the Matrix disposition and associated with certain costs related to MK Medical, partially offset by an increase in net operating loss carryforwards.
24
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 9. | Stockholders Equity |
During July 2004, we filed two registration statements on Form S-8 with the SEC registering 5.3 million shares of our common stock issuable under the 1997 Long-Term Incentive Plan and 450,000 shares of our common stock issuable under our Non-Employee Directors Stock Option Plan. During March 2004, we filed a registration statement on Form S-8 with the SEC relating to 1.0 million shares of our common stock issuable to eligible persons in accordance with the terms of our 401(k) SavingsPlus Plan.
We currently do not recognize compensation expense for our stock option grants, which are issued at fair market value on the date of grant and are accounted for under the intrinsic value method. We are in compliance with the current accounting rules regarding stock-based compensation. On June 30, 2004, the FASB issued an Exposure Draft, Share-Based Payment, which will require all share-based payments to employees, including grants of employee stock options, to be expensed in the statements of income based on their fair values. The FASB currently expects the new standard will be issued during December 2004, with an anticipated effective date for reporting periods beginning after June 15, 2005, and require expensing of all options that remain unvested as of the effective date, among other things.
For purposes of pro forma disclosures, the estimated fair market value of all outstanding stock options is amortized to expense over the respective vesting periods. The fair market value has been estimated at the date of grant using a Black-Scholes option-pricing model. The pro forma effects are not necessarily indicative of the effects on future quarters or future years. The following table summarizes our unaudited pro forma net income and diluted net income per share assuming we accounted for our stock option grants using the fair value method (in thousands, except per share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
Reported net income(a)
|
$ | 24,400 | $ | 9,983 | $ | 21,916 | $ | 39,662 | ||||||||
Stock option compensation expense
|
1,025 | 1,801 | 4,132 | 5,090 | ||||||||||||
Pro forma net income
|
$ | 23,375 | $ | 8,182 | $ | 17,784 | $ | 34,572 | ||||||||
Reported diluted net income per share
|
$ | 0.22 | $ | 0.09 | $ | 0.20 | $ | 0.37 | ||||||||
Pro forma diluted net income (loss) per share
|
$ | 0.21 | $ | 0.08 | $ | 0.16 | $ | 0.33 | ||||||||
(a) | Includes total charges to our condensed consolidated statements of income related to restricted stock grants for the three-month periods ended September 30, 2004 and 2003 of approximately $1.1 million and $619,000, respectively, and for the nine-month periods ended September 30, 2004 and 2003 of approximately $2.7 million and $1.4 million, respectively. |
Note 10. | Contingencies and Legal Proceedings |
We are contingently liable for approximately $12.3 million of long-term debt maturing on various dates through 2019, as well as annual interest on that debt. These contingent liabilities principally arose from previous sales of nursing facilities and assisted living centers. We also guarantee certain third-party operating leases. These guarantees arose from our dispositions of leased facilities, of which the underlying leases have $62.7 million of minimum rental commitments remaining through the initial lease terms. In accordance with the FASBs Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, we have recorded a liability of approximately
25
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 10. | Contingencies and Legal Proceedings (Continued) |
$660,000 as of September 30, 2004, included in Other accrued liabilities on the condensed consolidated balance sheets, as the estimated fair value of guarantees entered into or modified since January 1, 2003.
As discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2003, as amended, and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2004, the following derivative lawsuits were filed in the state court of Arkansas, as well as the federal district court in Arkansas, assertedly on behalf of the Company (collectively, the Derivative Actions):
| Norman M. Lyons v. David R. Banks, et. al., Case No. OT99-4041, was filed in the Chancery Court of Pulaski County, Arkansas (4th Division) on or about July 29, 1999, and the parties filed an Agreed Motion to Stay the proceedings on January 17, 2000; | |
| Badger v. David R. Banks, et. al., Case No. LR-C-99-881, was filed in the United States District Court for the Eastern District of Arkansas (Western Division) on November 30, 1999; and | |
| Richardson v. David R. Banks, et. al., Case No. LR-C-99-826, was filed in the United States District Court for the Eastern District of Arkansas (Western Division) on November 4, 1999. |
The Badger and Richardson actions were ordered to be consolidated as In re Beverly Enterprises, Inc. Derivative Litigation and by agreed motion, plaintiffs filed an amended, consolidated complaint on April 21, 2000. On June 1, 2004, the parties filed with the court papers effectuating a settlement for these actions, as well as the Lyons action, which provides that we will incorporate various corporate governance practices that are consistent with our policies. In addition, the directors and officers liability insurance carriers, on behalf of the individual defendants, will pay no more than $375,000 for plaintiffs attorneys fees. The court approved the settlement on September 28, 2004, and the actions have been dismissed with prejudice.
As discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2003, as amended, and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2004, on October 31, 2002, a shareholder derivative action entitled Paul Dunne and Helene Dunne, derivatively on behalf of nominal defendant Beverly Enterprises, Inc. v. Beryl F. Anthony, Jr., et. al. was filed in the Circuit Court of Sebastian County, Arkansas, Fort Smith Division (No. CIV-2002-1241). This case was purportedly brought derivatively on our behalf against various current and former officers and directors. The complaint alleges causes of action for breach of fiduciary duty against the defendants based on: (1) allegations that defendants failed to establish and maintain adequate accounting controls such that we failed to record adequate reserves for patient care liability costs; and (2) allegations that certain defendants sold Company stock while purportedly in possession of material non-public information. On May 16, 2003, two additional derivative complaints (Holcombe v. Floyd, et. al. and Flowers v. Floyd, et. al.) were filed and subsequently transferred to the Circuit Court of Sebastian County, Arkansas, Fort Smith Division and consolidated with the Dunne action as Holcomb v. Beverly Enterprises, Inc. The Dunnes were subsequently dismissed as plaintiffs.
On June 9, 2003, pursuant to a stipulation of the parties, the court entered a scheduling order providing, among other things, that plaintiffs had thirty days from a ruling on the motion to dismiss filed by defendants in the securities class action in federal court, In re Beverly Enterprises, Inc. Securities Litigation (Case No. 2:02 cv 2190), to file an amended complaint and that defendants shall have thirty days thereafter to respond to the complaint. The court entered a ruling on the defendants motion to dismiss in the federal securities class action on December 23, 2003, and the plaintiffs filed a notice of appeal on January 22, 2004. In light of the plaintiffs appeal, the parties agreed to a further stay of this derivative action pending resolution of the appeal. The dismissal of the appeal on April 19, 2004, described above, began the thirty-day period for plaintiffs to file an amended complaint in the derivative action, which they declined to do. Defendants response to the complaint
26
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 10. | Contingencies and Legal Proceedings (Continued) |
was originally due on June 19, 2004. The court has extended the time for defendants to respond until November 19, 2004. Due to the preliminary state of this action, we are unable to assess the probable outcome of the case and can give no assurance of the ultimate impact on our financial position, results of operations and cash flows.
We are a party to various legal matters relating to patient care, including claims that our services have resulted in injury or death to residents of our facilities. Over the past few years, we have experienced an increasing trend in the number and severity of the claims asserted against us. We believe that there has been, and will continue to be, an increase in governmental investigations of long-term care providers. Adverse determinations in legal proceedings or governmental investigations, whether currently asserted or arising in the future, could have a material adverse effect on us.
There are various other lawsuits and regulatory actions pending against us arising in the normal course of business, some of which seek punitive damages that are generally not covered by insurance. We do not believe that the ultimate resolution of such other matters will have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Note 11. | Segment Information |
Statement of Financial Accounting Standards No. 131, Disclosures about Segments of an Enterprise and Related Information, provides disclosure guidelines for segments of a company based on a management approach to defining operating segments. Our operations are organized into three primary segments:
| Nursing Facilities, which provide long-term healthcare through the operation of skilled nursing homes and assisted living centers; | |
| Aegis, which provides rehabilitation therapy services under contract to our nursing facilities and facilities operated by other care providers; and | |
| Hospice/ Home Care, which primarily provides hospice services. |
27
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 11. | Segment Information (Continued) |
The following table summarizes certain information for each of our operating segments (in thousands):
Nursing | Hospice/ | Discontinued | |||||||||||||||||||||||
Facilities | Aegis(1) | Home Care | All Other(2) | Total | Operations(3) | ||||||||||||||||||||
Three Months Ended September 30,
2004
|
|||||||||||||||||||||||||
Revenues from external customers
|
$ | 455,684 | $ | 31,975 | $ | 19,247 | $ | 1,263 | $ | 508,169 | $ | 33,162 | |||||||||||||
Intercompany revenues
|
816 | 36,946 | | 612 | 38,374 | | |||||||||||||||||||
Depreciation and amortization
|
13,484 | 231 | 217 | 1,986 | 15,918 | 29 | |||||||||||||||||||
Interest expense
|
1,796 | | | 9,326 | 11,122 | 1 | |||||||||||||||||||
Interest income
|
458 | 8 | | 780 | 1,246 | (7 | ) | ||||||||||||||||||
Pre-tax income (loss)
|
26,415 | 9,697 | 2,863 | (17,282 | ) | 21,693 | 3,184 | ||||||||||||||||||
Goodwill
|
44,753 | | 79,714 | | 124,467 | 332 | |||||||||||||||||||
Total assets
|
852,537 | 31,079 | 97,526 | 338,402 | 1,319,544 | 15,128 | |||||||||||||||||||
Capital expenditures
|
14,529 | 255 | 287 | 717 | 15,788 | 263 | |||||||||||||||||||
Three Months Ended September 30,
2003
|
|||||||||||||||||||||||||
Revenues from external customers
|
$ | 429,082 | $ | 20,044 | $ | 10,369 | $ | 1,706 | $ | 461,201 | $ | 121,626 | |||||||||||||
Intercompany revenues
|
373 | 38,572 | | 490 | 39,435 | | |||||||||||||||||||
Depreciation and amortization
|
12,275 | 193 | 137 | 2,178 | 14,783 | 2,251 | |||||||||||||||||||
Interest expense
|
3,154 | | | 12,875 | 16,029 | 611 | |||||||||||||||||||
Interest income
|
693 | 8 | | 469 | 1,170 | 35 | |||||||||||||||||||
Pre-tax income (loss)
|
13,809 | 12,487 | 1,841 | (18,231 | ) | 9,906 | 1,930 | ||||||||||||||||||
Goodwill
|
44,529 | | 11,724 | 269 | 56,522 | 1,403 | |||||||||||||||||||
Total assets
|
892,698 | 18,983 | 21,319 | 258,753 | 1,191,753 | 148,624 | |||||||||||||||||||
Capital expenditures
|
8,270 | 352 | 288 | 1,721 | 10,631 | 1,054 | |||||||||||||||||||
Nine Months Ended September 30,
2004
|
|||||||||||||||||||||||||
Revenues from external customers
|
$ | 1,349,160 | $ | 89,023 | $ | 42,399 | $ | 5,722 | $ | 1,486,304 | $ | 125,962 | |||||||||||||
Intercompany revenues
|
1,902 | 112,228 | | 1,548 | 115,678 | | |||||||||||||||||||
Depreciation and amortization
|
39,147 | 650 | 427 | 6,017 | 46,241 | 1,415 | |||||||||||||||||||
Interest expense
|
6,034 | 1 | | 29,033 | 35,068 | 178 | |||||||||||||||||||
Interest income
|
1,719 | 13 | 1 | 2,356 | 4,089 | 20 | |||||||||||||||||||
Pre-tax income (loss)
|
68,249 | 34,530 | 6,439 | (79,374 | ) | 29,844 | (4,604 | ) | |||||||||||||||||
Goodwill
|
44,753 | | 79,714 | | 124,467 | 332 | |||||||||||||||||||
Total assets
|
852,537 | 31,079 | 97,526 | 338,402 | 1,319,544 | 15,128 | |||||||||||||||||||
Capital expenditures
|
31,919 | 742 | 418 | 3,946 | 37,025 | 939 | |||||||||||||||||||
Nine Months Ended September 30,
2003
|
|||||||||||||||||||||||||
Revenues from external customers
|
$ | 1,257,071 | $ | 55,444 | $ | 27,757 | $ | 4,758 | $ | 1,345,030 | $ | 456,638 | |||||||||||||
Intercompany revenues
|
416 | 117,901 | | 878 | 119,195 | | |||||||||||||||||||
Depreciation and amortization
|
36,972 | 619 | 428 | 5,615 | 43,634 | 9,211 | |||||||||||||||||||
Interest expense
|
9,116 | | 8 | 38,637 | 47,761 | 2,705 | |||||||||||||||||||
Interest income
|
1,865 | 25 | | 1,664 | 3,554 | 41 | |||||||||||||||||||
Pre-tax income (loss)
|
40,531 | 35,559 | 3,262 | (59,834 | ) | 19,518 | 24,434 | ||||||||||||||||||
Goodwill
|
44,529 | | 11,724 | 269 | 56,522 | 1,403 | |||||||||||||||||||
Total assets
|
892,698 | 18,983 | 21,319 | 258,753 | 1,191,753 | 148,624 | |||||||||||||||||||
Capital expenditures
|
17,099 | 991 | 336 | 6,284 | 24,710 | 4,344 |
(1) | Pre-tax income (loss) includes profit on intercompany revenues, which is eliminated in All Other. |
(2) | Includes the operations of our corporate headquarters and related overhead, as well as certain non-operating revenues and expenses. Such amounts also include a special pre-tax credit totaling $613,000 and a pre-tax charge of $1.3 million for the three months ended September 30, 2004 and 2003, respectively, and pre-tax charges of $1.2 million and $2.7 million for the nine months ended September 30, 2004 and 2003, respectively, for asset impairments, workforce reductions and other unusual items. (See Note 3.) |
(3) | In accordance with the provisions of SFAS No. 144, the results of operations of certain nursing facilities, clinics and other assets have been reclassified, for all periods presented, as discontinued operations. Pre-tax income (loss) includes net gains on sales and exit costs of $865,000 and net gains on sales of $5.5 million for the three months ended September 30, 2004 and 2003, respectively. Pre-tax income (loss) includes net losses on sales and exit costs of $3.1 million and net gains on sales of $27.2 million for the nine months ended September 30, 2004 and 2003, respectively. The remaining assets and liabilities of our former Matrix segment and the assets of 24 nursing facilities are classified as held for sale at September 30, 2004. (See Note 4.) |
28
REPORT OF ERNST & YOUNG LLP,
The Board of Directors
We have reviewed the accompanying condensed consolidated balance sheet of Beverly Enterprises, Inc. as of September 30, 2004, and the related condensed consolidated statements of income for the three-month and nine-month periods ended September 30, 2004 and 2003, and the condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2004 and 2003 (Form 10-Q). These financial statements are the responsibility of the Companys management.
We conducted our reviews in accordance with standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures to financial data and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with standards of the Public Company Accounting Oversight Board (United States), which will be performed for the full year with the objective of expressing an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the accompanying condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of Beverly Enterprises, Inc. as of December 31, 2003 and the related consolidated statements of operations, stockholders equity, and cash flows for the year then ended, not presented in the Companys Form 10-Q, and in our report dated September 21, 2004, except for Note 16, as to which the date was September 23, 2004, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2003, included in the Companys Form 10-Q, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
Fort Smith, Arkansas
29
BEVERLY ENTERPRISES, INC.
General
Overview |
Our results for the third quarter of 2004 were strong, both operationally and financially. Net income from continuing operations totaled $21.2 million (19 cents per share diluted) in the third quarter of 2004, compared to $8.1 million (7 cents per share diluted) in the 2003 third quarter. Revenues from continuing operations for the 2004 third quarter totaled $508.2 million, an increase of more than 10% from the comparable period in 2003. Nursing Facility revenues were up more than 6%, third-party revenues for Aegis were up 60% and Hospice/ Home Care recorded an 86% increase in revenue.
The revenue increase for Nursing Facilities reflects a 7.2% increase in the overall per diem rate and a continuing improvement in Medicare patients as a percentage of total patient days to 11.4%. Compared with the 2003 third quarter, our Medicare rate rose 9.8%, Medicaid rates increased 5.3% (4.8% net of the cost of provider taxes) and private and managed care rates were up 5.7%.
Aegis revenues reflect the net addition of 17 new customers during the quarter, as well as continued business expansion among existing customers. Revenues from our core Hospice/Home Care operations were up 33%, with the balance of this segments revenue growth coming from our July 30 acquisition of Hospice USA. Our integration of the 18 new hospice locations in Tennessee, Mississippi and Alabama into our existing hospice business is proceeding as anticipated. This acquisition is expected to contribute $1.8 million of pre-tax income for 2004. Including the acquisition, average daily hospice census for the 2004 third quarter was 1,792.
These revenue increases coupled with continued contributions from ongoing cost-control and refinancing initiatives contributed to a 119% increase in pre-tax income from continuing operations for the 2004 third quarter, compared to the year-earlier period.
We expect sustained operating improvements and tight cost controls to make 2004 another very strong year for us. We remain committed to maximizing current performance, while continuing to build a solid foundation for further profitable growth in 2005 and beyond.
Governmental Regulation |
We are subject to extensive regulation by federal, state and local agencies. Each of our facilities must comply with regulations regarding staffing levels, patient care standards, occupational health and safety, patient confidentiality, billing and reimbursement, as well as environmental and biological hazards, among others. Additionally, government agencies have steadily increased their enforcement activity in this industry over the past several years, particularly with respect to large for-profit, multi-facility providers like us. This regulatory environment may force us to expend considerable resources to ensure compliance and respond to inspections, investigations or other enforcement actions. We believe the government will continue aggressive enforcement in the future.
On February 3, 2000, we entered into a series of separate agreements with the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS). As part of this series of agreements, we entered into a civil settlement agreement pursuant to which we paid the federal government $25.0 million during the first quarter of 2000 and agreed to reimburse the federal government an additional $145.0 million through withholdings from our biweekly Medicare periodic interim payments in equal installments ending in the first quarter of 2008. As of September 30, 2004, the present value of the remaining obligation was $51.8 million. As a result of such withholdings, our cash flows from operations were negatively impacted by $13.9 million during the nine-month period ended September 30, 2004, and are expected to be negatively impacted at an annual rate of $18.1 million.
30
MANAGEMENTS DISCUSSION AND ANALYSIS
As part of this series of agreements, we entered into a Corporate Integrity Agreement with the OIG, which was subsequently revised in 2002 and 2004. This agreement requires that we monitor our activities, on an ongoing basis, to ensure our compliance with the requirements of participation in federal healthcare programs. It also includes functional and training obligations, audit and review requirements and record keeping and reporting requirements. The 2002 revisions were made to reflect a permanent injunction requiring our nursing facilities in California to conduct additional training programs and to hire an independent quality monitor for our nursing facilities in California, Arizona, Hawaii and Washington to assess our quality care systems. We have divested all of our nursing facilities in Arizona, Washington and Hawaii and a substantial portion of our nursing facilities in California. The 2004 revisions were made to extend the services of the quality monitor to all of our nursing facilities and to reflect a modification of the requirements under the agreement with respect to training and education.
We believe that we are generally in compliance with the requirements of our Corporate Integrity Agreement and file annual reports with the OIG documenting our compliance. If we fail to comply with our Corporate Integrity Agreement, we may be subject to penalties or exclusion from the Medicare and Medicaid programs, which could have an adverse effect on our financial condition and results of operations.
In the ordinary course of business, we periodically receive notices of deficiencies for allegations of failure to comply with various regulatory requirements. We review all such notices and take timely and appropriate corrective action. In most cases, the facility and the government will agree upon steps to be taken to bring the facility into compliance with regulatory requirements. In some cases or upon repeat violations, the government may take a number of adverse actions against the facility or us, including imposition of fines, temporary suspension of admission of new patients, decertification from participation in Medicare or Medicaid programs and licensure revocation. Also in the ordinary course of business, we periodically receive requests for information from various regulatory agencies about our facilities and operations. We review all such requests and take steps to provide timely and appropriate responses to the applicable agencies.
Critical Accounting Policy Update
Patient Care Liability and Insurance Risks |
General and professional liability costs for the long-term healthcare industry have become increasingly expensive and difficult to estimate. In addition, insurance coverage for patient care liability and certain other risks, for nursing facilities specifically and companies in general, has become increasingly difficult to obtain. When obtained, insurance carriers are often requiring companies to significantly increase their liability retention levels and pay substantially higher premiums for reduced terms of coverage. We have experienced higher premiums and retention levels in the past. Our insurance covering patient care liability and workers compensation was renewed in the second quarter of 2004, with retention levels remaining consistent and premiums being generally the same or less than the prior year. However, we cannot assure you that we will be able to renew our insurance coverages in future years on terms as favorable as those we currently have. The majority of our workers compensation and auto liability risks are insured through loss-sensitive insurance policies with affiliated and unaffiliated insurance companies. For our general and professional liabilities, we are responsible for the first dollar of each claim, up to a self-insurance limit determined by the individual policies, subject to aggregate limits in certain prior policy years.
Our liabilities for general, professional and workers compensation risk are estimated by our independent actuaries twice a year using the most recent trends of claims, settlements and other relevant data. On an undiscounted basis, these liabilities totaled approximately $197.9 million at September 30, 2004. On our financial statements, these liabilities are discounted at 10% to their present value using expected loss payment timing patterns. The discount rate is based upon our best estimate of the incremental borrowing rate that would be required to fund these liabilities with uncollateralized debt. A reduction in the discount rate by one-
31
MANAGEMENTS DISCUSSION AND ANALYSIS
half of a percentage point would have resulted in an additional pre-tax charge for the nine months ended September 30, 2004 of approximately $1.7 million. Based on information provided by our independent actuaries, we estimate our range of discounted exposure for these liabilities to be approximately $144.7 million to $164.7 million. At September 30, 2004, our recorded reserves for these liabilities totaled $153.7 million. We believe adequate provision has been made in our condensed consolidated financial statements for patient care, workers compensation and other insurance liabilities.
Stock-Based Awards
See Item 1. Note 9 for a summary of our pro forma net income and diluted net income per share assuming we accounted for all of our outstanding stock options using the fair value method in accordance with Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation.
Off-Balance Sheet Arrangements
On June 15, 2004, Beverly Funding Corporation (BFC) repaid $70.0 million of medium-term notes (the Medium-Term Notes). These notes were obligations of BFC, a bankruptcy remote, qualifying special purpose entity, which was not consolidated with us prior to the repayment of the notes. Upon repayment of the Medium-Term Notes, BFC no longer had third-party beneficial owners and no longer met the conditions of a qualifying special purpose entity. Therefore, during the second quarter of 2004, BFC was reconsolidated with us.
We are contingently liable for approximately $12.3 million of long-term debt maturing on various dates through 2019, as well as annual interest on that debt. These contingent liabilities principally arose from previous sales of nursing facilities and assisted living centers. We also guarantee certain third-party operating leases. Those guarantees arose from our dispositions of leased facilities and the underlying leases have $62.7 million of minimum rental commitments remaining through the initial lease terms. In accordance with the FASBs Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, we have recorded a liability of approximately $660,000 as of September 30, 2004, included in Other accrued liabilities on the condensed consolidated balance sheet, as the estimated fair value of guarantees entered into or modified since January 1, 2003.
Operating Results
Reclassification |
Results of operations for the three months ended September 30, 2004 and 2003 reflect certain asset dispositions during 2004 and 2003, and assets held for sale as of September 30, 2004, as discontinued operations. (See Item 1. Note 4.) The following discussions of Third Quarter 2004 Compared to Third Quarter 2003 and Nine Months 2004 Compared to Nine Months 2003 reflect this reclassification.
Third Quarter 2004 Compared to Third Quarter 2003 |
Results of Operations Continuing Operations |
We reported income from continuing operations for the third quarter of 2004 of $21.2 million, compared to income of $8.1 million for the same period in 2003. The income from continuing operations for the third quarter of 2004 included a special pre-tax credit of $613,000 related to the reversal of previously recorded charges (see Item 1. Note 3). Income from continuing operations for the third quarter of 2003 included special pre-tax charges for asset impairments, workforce reductions, exit costs and other unusual items of $1.3 million.
32
MANAGEMENTS DISCUSSION AND ANALYSIS
Revenues |
We reported revenues of $508.2 million during the third quarter of 2004, compared to $461.2 million for the same period in 2003. Approximately 90% and 93% of our revenues for the quarters ended September 30, 2004 and 2003, respectively, were derived from services provided by our Nursing Facilities segment. The increase in revenues of $47.0 million, or 10.2%, for the third quarter of 2004, as compared to the same period in 2003, is due to the following:
| an increase of $40.6 million from facilities we operated during each of the quarters ended September 30, 2004 and 2003 and organic growth from our service businesses (same facility operations); | |
| an increase of $8.8 million primarily due to a nursing facility acquisition, the Hospice USA acquisition, the opening of seven hospice locations and start-up businesses; offset by | |
| a decrease of $2.4 million due to dispositions during 2004 and 2003 which did not meet the criteria to be included in discontinued operations. |
The increase in revenues of $40.6 million from same facility operations for the third quarter of 2004, as compared to the same period in 2003, primarily consists of the following:
| increase of $11.9 million, $9.3 million and $3.2 million in Medicaid, Medicare and private payment rates, respectively; | |
| an increase of $11.9 million due to growth in Aegis external therapy business; | |
| an increase of $2.8 million due to growth in our Hospice/ Home Care business; offset by | |
| a decrease of $1.6 million due to a decline in same facility census. |
Costs and Expenses |
We reported costs and expenses of $477.0 million during the third quarter of 2004 compared to $436.4 million for the same period in 2003. Excluding special net pre-tax credits of $613,000 in 2004 and a special pre-tax charge of $1.3 million in 2003, discussed above, our costs and expenses increased $42.5 million, or 9.8%, consisting of the following:
| an increase of $39.0 million in same facility operations; | |
| an increase of $7.5 million primarily due to a nursing facility acquisition, the Hospice USA acquisition, the opening of seven hospice locations and start-up businesses; offset by | |
| a decrease of $4.0 million due to dispositions during 2004 and 2003 not reported as discontinued operations. |
The increase in costs and expenses of $39.0 million from same facility operations for the third quarter of 2004, as compared to the same period in 2003, was due primarily to the following:
| a net increase of $22.8 million in wages and related expenses, primarily due to a 3.8% increase in our weighted average wage rate and 1.3% increase in nursing hours per patient day; | |
| an increase of $3.8 million in contracted services; | |
| an increase of $1.5 million in our provision for insurance; | |
| an increase of $1.4 million in state-imposed provider taxes; and | |
| an increase of $1.1 million in depreciation and amortization expense, primarily due to capital expenditures. |
33
MANAGEMENTS DISCUSSION AND ANALYSIS
Interest Expense |
Interest expense decreased 31% to $11.1 million for the third quarter of 2004, as compared to $16.0 million for the same period in 2003, primarily due to the October 2003 refinancing of our credit facility and our 9% senior notes and the reduction of debt using the proceeds from sales of facilities, clinics and other assets in 2003.
Results of Operations Discontinued Operations |
The results of operations of disposed facilities and other assets in the three months ended September 30, 2004, as well as the results of operations of held-for-sale assets, have been reported as discontinued operations for all periods presented in the accompanying condensed consolidated statements of income. Also included in discontinued operations are gains and losses on sales, additional impairments and exit costs relative to these transactions. Discontinued operations for the three months ended September 30, 2003 also include the results of operations for facilities, clinics and businesses disposed of during 2003. A summary of discontinued operations by operating segment, is as follows (in thousands):
2004 | 2003 | |||||||||||||||||||||||||||||||
Home | Nursing | Home | Nursing | |||||||||||||||||||||||||||||
Matrix | Care | Facilities | Total | Matrix | Care | Facilities | Total | |||||||||||||||||||||||||
Three Months Ended September 30
|
||||||||||||||||||||||||||||||||
Revenues
|
$ | 3,563 | $ | | $ | 29,599 | $ | 33,162 | $ | 3,314 | $ | 2,539 | $ | 115,773 | $ | 121,626 | ||||||||||||||||
Operating income (loss)(a)
|
$ | 211 | 33 | $ | 2,075 | $ | 2,319 | $ | 228 | $ | (1,099 | ) | $ | (2,681 | ) | $ | (3,552 | ) | ||||||||||||||
Gain (loss) on sales and exit costs
|
(24 | ) | 366 | 472 | 814 | | 309 | 6,871 | 7,180 | |||||||||||||||||||||||
Impairments and other unusual items
|
| | 51 | 51 | | | (1,698 | ) | (1,698 | ) | ||||||||||||||||||||||
Pre-tax income (loss)
|
$ | 187 | $ | 399 | $ | 2,598 | 3,184 | $ | 228 | $ | (790 | ) | $ | 2,492 | 1,930 | |||||||||||||||||
Benefit from income taxes
|
(59 | ) | | |||||||||||||||||||||||||||||
Discontinued operations, net of taxes
|
$ | 3,243 | $ | 1,930 | ||||||||||||||||||||||||||||
(a) | Includes net interest expense of $8,000 and $576,000 for 2004 and 2003, respectively. Also includes depreciation and amortization of $29,000 and $2.3 million for 2004 and 2003, respectively. |
Nine Months 2004 Compared to Nine Months 2003 |
Results of Operations Continuing Operations |
We reported income from continuing operations for the nine months ended September 30, 2004 of $26.8 million, compared to $15.2 million for the same period in 2003. Income from continuing operations for the nine months ended September 30, 2004 included pre-tax charges of $40.4 million for the refinancing of our 9 5/8% senior notes (see below) as well as asset impairments, workforce reductions and other unusual items totaling $1.2 million. (See Item 1. Note 3.) Income from continuing operations for the nine months ended September 30, 2003 included special pre-tax charges for asset impairments, workforce reductions and other unusual items of $2.7 million and the reversal of $925,000 related to a settlement and related costs accrued for the investigation of patient care issues at certain California nursing homes.
Revenues |
We reported revenues of $1,486.3 million during the nine months ended September 30, 2004, compared to $1,345.0 million for the same period in 2003. Approximately 91% and 93% of our revenues for the nine
34
MANAGEMENTS DISCUSSION AND ANALYSIS
months ended September 30, 2004 and 2003, respectively, were derived from services provided by our Nursing Facilities segment. The increase in revenues of $141.3 million, or 10.5%, consists of the following:
| an increase of $127.3 million from facilities we operated during each of the nine month periods ended September 30, 2004 and 2003 and organic growth from our service businesses (same facility operations); | |
| an increase of $20.5 million primarily due to one nursing facility acquisition, the Hospice USA acquisition, the openings of seven hospice locations and start-up businesses; offset by | |
| a decrease of $6.5 million due to the dispositions of certain nursing facilities during 2004 and 2003 which did not meet the criteria to be included in discontinued operations. |
The increase in revenues of $127.3 million from same facility operations for the nine months ended September 30, 2004, as compared to the same period in 2003, consists primarily of the following:
| increases of $43.6 million, $27.3 million and $9.0 million in Medicaid, Medicare and private payment rates, respectively; | |
| an increase of $33.6 million due to growth in Aegis external therapy business; | |
| an increase of $6.4 million due to growth in our Hospice/ Home Care business; | |
| an increase of $4.4 million due to one additional calendar day during the first nine months of 2004, as compared to the same period in 2003; | |
| an increase of $2.8 million due to a positive shift in our patient mix; offset by | |
| a decrease of $6.9 million due to a decline in same facility census. |
Costs and Expenses |
We reported costs and expenses of $1,385.7 million during the nine months ended September 30, 2004 compared to $1,281.7 million for the same period in 2003. Excluding special net pre-tax charges of $1.2 million and $1.7 million in 2004 and 2003, respectively, discussed above, our costs and expenses increased $104.5 million, or 8.2%, consisting of the following:
| an increase of $95.7 million in same facility operations; | |
| an increase of $16.2 million primarily due to one nursing facility acquisition, the Hospice USA acquisition, and the openings of seven hospice locations and start-up businesses; offset by | |
| a decrease of $7.4 million due to dispositions during 2004 and 2003 that did not meet the criteria to be reported as discontinued operations. |
The increase in costs and expenses of $95.7 million from same facility operations for the nine months ended September 30, 2004, as compared to the same period in 2003, was due primarily to the following:
| a net increase of $49.6 million in wages and related expenses, primarily due to a 3.5% increase in our weighted average wage rate and an increase in nursing hours per patient day, partially offset by an adjustment in reserves related to new employee benefit programs implemented in 2003; | |
| an increase of $9.8 million in contracted services; | |
| an increase of $8.2 million in our provision for insurance, primarily due to an increase in the estimate of retained losses for prior policy years and an increase in related costs; | |
| an increase of $7.6 million in state-imposed provider taxes; and |
35
MANAGEMENTS DISCUSSION AND ANALYSIS
| an increase of $2.8 million in depreciation and amortization expense, primarily due to capital expenditures. |
Costs Related to Early Extinguishments of Debt |
During June 2004, we issued $215.0 million of 7 7/8% senior subordinated notes. The proceeds from the senior subordinated notes, together with cash on hand, were used to purchase for cash $190.6 million of our 9 5/8% senior notes tendered and to pay related fees and expenses. In conjunction with these transactions, we paid a prepayment premium of $36.1 million related to the early extinguishments of the 9 5/8% senior notes and wrote off $3.7 million of related deferred financing costs. We also paid $681,000 in fees and expenses related to the cash tender offer for the 9 5/8% senior notes.
Interest Expense |
Interest expense decreased 27% to $35.1 million for the nine months ended September 30, 2004, as compared to $47.8 million for the same period in 2003, primarily due to the October 2003 refinancing of our credit facility and our 9% senior notes and to the reduction of debt using the proceeds from sales of facilities, clinics and other assets in 2003.
Income Taxes |
We recorded a provision for income taxes of $3.3 million for the nine months ended September 30, 2004, including $3.0 million from continuing operations and $286,000 from discontinued operations, primarily related to state income taxes. We decreased the valuation allowance on our deferred tax assets by $19.5 million during the nine months ended September 30, 2004 to $149.6 million primarily due to the reversal of temporary differences and the utilization of net operating loss carryforwards to offset taxable income. This valuation allowance is required under the guidance of Statement of Financial Accounting Standards No. 109, Accounting for Income Taxes, due to our historical operating performance and our reported cumulative net losses. Our realization of the deferred tax benefits, primarily associated with our net operating losses, is dependent upon our achieving sufficient future pre-tax income. Under federal income tax regulations, we have up to 20 years to generate sufficient taxable income to realize the deferred benefits. However, given the size of our pre-tax losses in prior years, a valuation allowance is considered to be appropriate under the more stringent accounting standards for the realization of these deferred tax benefits, which is contingent upon future income in the near term.
Results of Operations Discontinued Operations |
The results of operations of disposed facilities, clinics and other assets in the nine-month period ended September 30, 2004, as well as the results of operations of held-for-sale assets, have been reported as discontinued operations for all periods presented in the accompanying condensed consolidated statements of income. Also included in discontinued operations are gains and losses on sales, additional impairments and
36
MANAGEMENTS DISCUSSION AND ANALYSIS
exit costs relative to these transactions. A summary of the discontinued operations is as follows (in thousands):
2004 | 2003 | |||||||||||||||||||||||||||||||
Home | Nursing | Home | Nursing | |||||||||||||||||||||||||||||
Matrix | Care | Facilities | Total | Matrix | Care | Facilities | Total | |||||||||||||||||||||||||
Nine Months Ended September 30
|
||||||||||||||||||||||||||||||||
Revenues
|
$ | 10,466 | $ | 148 | $ | 115,348 | $ | 125,962 | $ | 14,847 | $ | 20,184 | $ | 421,607 | $ | 456,638 | ||||||||||||||||
Operating income (loss)(a)
|
$ | 859 | 1 | $ | (2,319 | ) | $ | (1,459 | ) | $ | 336 | $ | (2,092 | ) | $ | (1,002 | ) | $ | (2,758 | ) | ||||||||||||
Gain (loss) on sales and exit costs
|
(49 | ) | 369 | (610 | ) | (290 | ) | 10,940 | 929 | 34,691 | 46,560 | |||||||||||||||||||||
Impairments and other unusual items(b)
|
| | (2,855 | ) | (2,855 | ) | | (540 | ) | (18,828 | ) | (19,368 | ) | |||||||||||||||||||
Pre-tax income (loss)
|
$ | 810 | $ | 370 | $ | (5,784 | ) | (4,604 | ) | $ | 11,276 | $ | (1,703 | ) | $ | 14,861 | 24,434 | |||||||||||||||
Provision for income taxes
|
286 | | ||||||||||||||||||||||||||||||
Discontinued operations, net of taxes
|
$ | (4,890 | ) | $ | 24,434 | |||||||||||||||||||||||||||
(a) | Includes net interest expense of $158,000 and $2.7 million for 2004 and 2003. Also includes depreciation and amortization of $1.4 million and $9.2 million for 2004 and 2003, respectively. | |
(b) | Includes an accrual in 2003 for the purchase of incremental patient care liability insurance on disposed nursing facilities. |
Liquidity and Capital Resources
Cash and Cash Flows. At September 30, 2004, we had $207.4 million in cash and cash equivalents. We anticipate that $55.9 million of this cash balance, while not legally restricted, will be utilized primarily to fund certain patient care liabilities and workers compensation claims and expenses. At September 30, 2004, we had positive working capital of $152.2 million reflected on our condensed consolidated balance sheet. Our cash flows consisted of the following (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | |||||||||||||||
2004 | 2003 | 2004 | 2003 | |||||||||||||
Net cash provided by operating activities
|
$ | 59,696 | $ | 32,981 | $ | 37,720 | $ | 53,427 | ||||||||
Net cash provided by (used for) investing
activities
|
(65,306 | ) | 23,541 | (51,147 | ) | 129,824 | ||||||||||
Net cash used for financing activities
|
(3,493 | ) | (22,339 | ) | (38,028 | ) | (129,979 | ) | ||||||||
Net increase (decrease) in cash and cash
equivalents
|
$ | (9,103 | ) | $ | 34,183 | $ | (51,455 | ) | $ | 53,272 | ||||||
37
MANAGEMENTS DISCUSSION AND ANALYSIS
Net cash provided by operating activities, under the direct method, for the nine months ended September 30, consists of the following (in thousands):
2004 | 2003 | |||||||
Cash received from patients and third-party payors
|
$ | 1,558,311 | $ | 1,781,515 | ||||
Interest received
|
4,109 | 3,595 | ||||||
Cash paid to suppliers and employees
|
(1,487,910 | ) | (1,683,868 | ) | ||||
Interest paid
|
(30,969 | ) | (45,799 | ) | ||||
Income taxes paid
|
(5,821 | ) | (2,016 | ) | ||||
Net cash provided by operating activities
|
$ | 37,720 | $ | 53,427 | ||||
With the termination of daily purchases of receivables by BFC from BHRS on March 1, 2004, accounts receivable on our condensed consolidated balance sheet have increased. This also resulted in an $82.0 million detriment to cash from operating activities on our condensed consolidated statement of cash flows for the nine months ended September 30, 2004.
For the nine months ended September 30, 2004, proceeds from dispositions and collections on notes receivable totaling $54.6 million, as well as cash on hand, were used to fund capital expenditures of $38.0 million and the acquisition of Hospice USA.
Debt Transactions. At September 30, 2004, we had $61.1 million of availability under our $90.0 million revolving credit facility, with $28.9 million being utilized for standby letters of credit primarily in support of certain insurance programs, security deposits, and debt or guaranteed debt obligations. During October 2004, we entered into a $40.0 million letter of credit facility. We expect to transfer our outstanding letter of credit commitments under our revolving credit facility to the new letter of credit facility thereby increasing our availability under the revolving credit facility to the full $90.0 million.
During June 2004, we commenced a cash tender offer to purchase any and all of our $200.0 million principal amount outstanding 9 5/8% senior notes due 2009 at an offer price of $1,190 per $1,000 principal amount tendered, plus accrued and unpaid interest, and a solicitation of consents to amend the indenture under which the 9 5/8% senior notes were issued. As of September 30, 2004, holders of $190.6 million of the 9 5/8% senior notes had tendered their notes and delivered consents. During June 2004, we issued $215.0 million of 7 7/8% senior subordinated notes due June 15, 2014 (the Senior Subordinated Notes). The Senior Subordinated Notes were issued at a discount (98.318% of par) to yield 8.125%. The Senior Subordinated Notes are general unsecured obligations subordinated in right of payment to our existing and future senior unsubordinated indebtedness and are guaranteed by certain of our subsidiaries. The Senior Subordinated Notes were issued through a private placement. We filed a registration statement with the SEC on September 23, 2004, to affect an exchange offer of these notes for publicly tradable notes.
The proceeds from the Senior Subordinated Notes, together with cash on hand, were used to purchase for cash $190.6 million of our 9 5/8% senior notes tendered, as well as to pay related fees and expenses. We recorded a pre-tax charge of $40.4 million related to this transaction, including $36.1 million for the prepayment premium and $3.7 million for the write-off of deferred financing costs on the 9 5/8% senior notes, as well as $681,000 for fees and expenses related to the cash tender offer. Approximately $36.1 million of the pre-tax charge, and $4.1 million of deferred financing costs related to the 7 7/8% senior subordinated notes, were paid out in cash, using $20.6 million of net proceeds from the issuance of the 7 7/8% senior subordinated notes and $19.6 million of cash on hand.
During the second quarter of 2004, we entered into two amendments to our senior credit facility which, among other things, permitted the issuance of the Senior Subordinated Notes and the purchase of our
38
MANAGEMENTS DISCUSSION AND ANALYSIS
9 5/8% senior notes, reduced the interest rate on the term loan portion of the senior credit facility, increased the size of our revolving credit facility from $75.0 million to $90.0 million and modified certain financial covenant levels.
Stock Repurchase Program. In November 2003, the Board of Directors authorized a stock repurchase program whereby we may repurchase, from time to time on the open market, up to $20.0 million of our outstanding common stock. The stock repurchase program became effective on December 1, 2003 and remains in effect for one year. As of September 30, 2004, no shares had been repurchased under this authorization and any such repurchases will only occur during open trading windows, if at all.
Acquisitions and Divestitures. On July 30, 2004, we purchased substantially all of the assets of Hospice USA, LLC, and its affiliates, which were privately held companies providing hospice services in Mississippi, Alabama and Tennessee, for cash of approximately $69.1 million. At the time of acquisition, Hospice USA, LLC and its affiliates operated 18 hospice locations and had an additional 16 locations under development. The acquisition was part of our ongoing strategy to expand our service businesses.
We expect the successful completion of our divestiture strategy, while resulting in a significant reduction in our revenues, will reduce our patient care liability costs, reduce outstanding debt and strengthen the nursing facility portfolio going forward. We expect to continue the implementation of initiatives to improve our fundamental business processes and reduce costs throughout the organization through 2005. We can give no assurance that we will be able to execute the divestiture strategy in a timely manner at fair values or that we will be able to reduce costs to achieve our objective within the time period projected.
We currently anticipate that cash on hand, cash flows from operations and availability under our banking arrangements will be adequate to repay our debts due within one year of $11.6 million, to make capital additions and improvements of approximately $80.0 million, to make operating lease and other contractual obligation payments, to make selective acquisitions, including previously leased facilities, to repurchase shares of our common stock and to meet working capital requirements for the twelve months ending September 30, 2005. If cash flows from operations or availability under our existing banking arrangements fall below expectations, we may be required to utilize cash on hand, delay capital expenditures, dispose of certain assets, issue additional debt securities, or consider other alternatives to improve liquidity.
Obligations and Commitments
On October 6, 2004, we entered into a $40.0 million letter of credit facility maturing in October 2008. The new facility is secured by certain of our Medicaid and Veterans Administration accounts receivable and contains standard terms and conditions, including a 2.375% fee on the outstanding letters of credit under the facility. Our lease guarantees described above in Off-Balance Sheet Arrangements increased due to disposition of leased facilities during the nine months ended September 30, 2004.
39
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
During the nine months ended September 30, 2004, we repaid $190.6 million of our 9 5/8% senior notes due 2009 and BFC repaid its $70.0 million variable rate off-balance sheet obligation. We also issued $215.0 million of fixed rate debt, through the issuance of 7 7/8% Senior Subordinated Notes due June 15, 2014. Our notes receivable decreased by a net $21.6 million due to collections.
ITEM 4. | CONTROLS AND PROCEDURES. |
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms. Such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As required by SEC Rule 13a-15(b), we have carried out an evaluation as of September 30, 2004, the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation and subject to the foregoing, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.
There has been no significant change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
40
PART II
BEVERLY ENTERPRISES, INC.
ITEM 1. | LEGAL PROCEEDINGS. |
Information regarding our legal proceedings is set forth in Note 10 to Condensed Consolidated Financial Statements, Commitments and Contingencies, in Part I Item 1 of this Form 10-Q, which information is incorporated herein by reference.
ITEM 6. | EXHIBITS. |
Exhibit | ||||
Number | ||||
3 | .1 |
Form of Restated Certificate of Incorporation of
New Beverly Holdings, Inc. (incorporated by reference to
Exhibit 3.1 to Beverly Enterprises, Inc.s Annual
Report on Form 10-K for the year ended December 31, 1997)
|
||
3 | .2 |
Form of Certificate of Amendment of Certificate
of Incorporation of New Beverly Holdings, Inc., changing its
name to Beverly Enterprises, Inc. (incorporated by reference to
Exhibit 3.2 to Beverly Enterprises, Inc.s Annual
Report on Form 10-K for the year ended December 31, 1997)
|
||
3 | .3 |
By-Laws of Beverly Enterprises, Inc.
(incorporated by reference to Exhibit 3.4 to Beverly
Enterprises, Inc.s Registration Statement on Form S-1
filed on June 4, 1997 (File No. 333-28521))
|
||
10 | .1 |
Credit Agreement, dated as of October 6,
2004, among Beverly Funding Corporation, Merrill Lynch Capital
(as agent and lender) and Additional Lenders From Time to Time
Party Thereto (incorporated by reference to Exhibit 10.1 to
Beverly Enterprises, Inc.s Form 8-K filed on
October 7, 2004)
|
||
10 | .2 |
Form of Long-Term Incentive Plan Notice
|
||
10 | .3 |
Form of Restricted Stock Agreement for Beverly
Enterprises, Inc. Non-Employee Directors Stock Option Plan
|
||
10 | .4 |
Form of Restricted Stock Agreement for Beverly
Enterprises, Inc. 1997 Long-Term Incentive Plan
|
||
10 | .5 |
Form of Option Agreement for Beverly Enterprises,
Inc. Non-Employee Directors Stock Option Plan
|
||
10 | .6 |
Form of Option Agreement for Beverly Enterprises,
Inc. 1997 Long-Term Incentive Plan
|
||
15 |
Acknowledgement Letter of Ernst & Young
LLP re: Unaudited Condensed Consolidated Interim Financial
Statements
|
|||
31 | .1 |
Rule 13a-14(a)/15d-14(a) Certification of Chief
Executive Officer
|
||
31 | .2 |
Rule 13a-14(a)/15d-14(a) Certification of Chief
Financial Officer
|
||
32 | .1 |
Section 1350 Certification of Chief
Executive Officer
|
||
32 | .2 |
Section 1350 Certification of Chief
Financial Officer
|
41
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BEVERLY ENTERPRISES, INC. | |
Registrant |
By: | /s/ PAMELA H. DANIELS |
|
|
Pamela H. Daniels | |
Senior Vice President, Controller | |
and Chief Accounting Officer |
Dated: November 9, 2004
42